CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: valdecoxib
Accession: CHEBI:63634
browse the term
Definition: A member of the class of isoxazoles that is isoxazole which is substituted at positions 3, 4 and 5 by phenyl, p-sulfamoylphenyl and methyl groups, respectively. A selective cyclooxygenase 2-inhibitor, it used as a nonsteroidal anti-inflammatory drug (NSAID) for the treatment of arthritis from 2001 until 2005, when it was withdrawn following concerns of an associated increased risk of heart attack and stroke.
Synonyms: exact_synonym: 4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide
related_synonym: 4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide; Bextra; Formula=C16H14N2O3S; InChI=1S/C16H14N2O3S/c1-11-15(12-7-9-14(10-8-12)22(17,19)20)16(18-21-11)13-5-3-2-4-6-13/h2-10H,1H3,(H2,17,19,20); InChIKey=LNPDTQAFDNKSHK-UHFFFAOYSA-N; SMILES=Cc1onc(-c2ccccc2)c1-c1ccc(cc1)S(N)(=O)=O; p-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide; valdecoxibum
alt_id: CHEBI:41662
xref: CAS:181695-72-7; DrugBank:DB00580; Drug_Central:2799; HMDB:HMDB0005033; KEGG:D02709; LINCS:LSM-5305
xref_mesh: MESH:C406224
xref: PDBeChem:COX; PMID:20467258; PMID:20717044; PMID:21073910; PMID:21720517; PMID:21769548; Reaxys:8563786; Wikipedia:Valdecoxib
G
Aadac
arylacetamide deacetylase
decreases expression
EXP
valdecoxib results in decreased expression of AADAC mRNA
CTD
PMID:24136188
NCBI chr 2:146,293,449...146,351,061
Ensembl chr 2:144,135,319...144,174,734
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases expression
EXP
valdecoxib results in increased expression of ABCB1 mRNA
CTD
PMID:24136188
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
G
Abcb4
ATP binding cassette subfamily B member 4
increases expression
EXP
valdecoxib results in increased expression of ABCB4 mRNA
CTD
PMID:24136188
NCBI chr 4:26,106,895...26,164,440
Ensembl chr 4:25,151,953...25,209,202
G
Abcc2
ATP binding cassette subfamily C member 2
increases expression
EXP
valdecoxib results in increased expression of ABCC2 mRNA
CTD
PMID:24136188
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
increases expression
EXP
valdecoxib results in increased expression of ABCC3 mRNA
CTD
PMID:24136188
NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,296,693...79,342,595
G
Abcc8
ATP binding cassette subfamily C member 8
decreases expression
EXP
valdecoxib results in decreased expression of ABCC8 mRNA
CTD
PMID:24136188
NCBI chr 1:105,734,992...105,816,272
Ensembl chr 1:96,598,647...96,679,510
G
Abcc9
ATP binding cassette subfamily C member 9
decreases expression
EXP
valdecoxib results in decreased expression of ABCC9 mRNA
CTD
PMID:24136188
NCBI chr 4:177,262,848...177,386,837
Ensembl chr 4:175,532,547...175,655,356
G
Abcg5
ATP binding cassette subfamily G member 5
increases expression
EXP
valdecoxib results in increased expression of ABCG5 mRNA
CTD
PMID:24136188
NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:9,965,118...9,990,563
G
Abhd4
abhydrolase domain containing 4, N-acyl phospholipase B
increases expression
EXP
valdecoxib results in increased expression of ABHD4 mRNA
CTD
PMID:24136188
NCBI chr15:31,674,090...31,686,051
Ensembl chr15:27,704,113...27,716,966
G
Acaca
acetyl-CoA carboxylase alpha
decreases expression
EXP
valdecoxib results in decreased expression of ACACA mRNA
CTD
PMID:24136188
NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,014,170...69,276,457
G
Acat2
acetyl-CoA acetyltransferase 2
increases expression
EXP
valdecoxib results in increased expression of ACAT2 mRNA
CTD
PMID:24136188
NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:47,695,788...47,752,821
G
Acbd6
acyl-CoA binding domain containing 6
increases expression
EXP
valdecoxib results in increased expression of ACBD6 mRNA
CTD
PMID:24136188
NCBI chr13:67,726,786...67,863,392
Ensembl chr13:67,726,786...67,862,311
G
Acly
ATP citrate lyase
decreases expression
EXP
valdecoxib results in decreased expression of ACLY mRNA
CTD
PMID:24136188
NCBI chr10:85,912,402...85,964,605
Ensembl chr10:85,412,049...85,463,320
G
Aco1
aconitase 1
increases expression
EXP
valdecoxib results in increased expression of ACO1 mRNA
CTD
PMID:24136188
NCBI chr 5:60,055,895...60,111,920
Ensembl chr 5:55,259,827...55,316,391
G
Acot13
acyl-CoA thioesterase 13
decreases expression
EXP
valdecoxib results in decreased expression of ACOT13 mRNA
CTD
PMID:24136188
NCBI chr17:40,668,404...40,680,876
Ensembl chr17:40,240,378...40,252,851
G
Acot2
acyl-CoA thioesterase 2
increases expression
EXP
valdecoxib results in increased expression of ACOT2 mRNA
CTD
PMID:24136188
NCBI chr 6:109,341,426...109,352,818
Ensembl chr 6:103,611,544...103,619,245
G
Acot4
acyl-CoA thioesterase 4
increases expression
EXP
valdecoxib results in increased expression of ACOT4 mRNA
CTD
PMID:24136188
NCBI chr 6:109,399,032...109,405,138
Ensembl chr 6:103,668,753...103,673,917
G
Acox3
acyl-CoA oxidase 3, pristanoyl
decreases expression
EXP
valdecoxib results in decreased expression of ACOX3 mRNA
CTD
PMID:24136188
NCBI chr14:79,358,604...79,405,160
Ensembl chr14:75,094,676...75,176,205
G
Acsl5
acyl-CoA synthetase long-chain family member 5
decreases expression
EXP
valdecoxib results in decreased expression of ACSL5 mRNA
CTD
PMID:24136188
NCBI chr 1:264,294,851...264,341,943
Ensembl chr 1:254,292,521...254,336,607
G
Actl6a
actin-like 6A
increases expression
EXP
valdecoxib results in increased expression of ACTL6A mRNA
CTD
PMID:24136188
NCBI chr 2:117,413,206...117,436,758
Ensembl chr 2:115,492,285...115,508,401
G
Adam15
ADAM metallopeptidase domain 15
decreases expression
EXP
valdecoxib results in decreased expression of ADAM15 mRNA
CTD
PMID:24136188
NCBI chr 2:177,052,363...177,062,879
Ensembl chr 2:174,754,633...174,765,113
G
Adamts9
ADAM metallopeptidase with thrombospondin type 1 motif, 9
decreases expression
EXP
valdecoxib results in decreased expression of ADAMTS9 mRNA
CTD
PMID:24136188
NCBI chr 4:126,847,726...127,019,924
Ensembl chr 4:125,291,490...125,462,929
G
Adamtsl4
ADAMTS-like 4
increases expression
EXP
valdecoxib results in increased expression of ADAMTSL4 mRNA
CTD
PMID:24136188
NCBI chr 2:183,235,634...183,247,091
Ensembl chr 2:183,235,646...183,246,848
G
Adgrv1
adhesion G protein-coupled receptor V1
decreases expression
EXP
valdecoxib results in decreased expression of ADGRV1 mRNA
CTD
PMID:24136188
NCBI chr 2:13,067,149...13,647,407
Ensembl chr 2:11,331,442...11,911,688
G
Adh1c
alcohol dehydrogenase 1C (class I), gamma polypeptide
decreases expression
EXP
valdecoxib results in decreased expression of ADH1 mRNA
CTD
PMID:24136188
NCBI chr 2:229,470,703...229,482,291
Ensembl chr 2:226,797,303...226,808,892
G
Adhfe1
alcohol dehydrogenase, iron containing, 1
decreases expression
EXP
valdecoxib results in decreased expression of ADHFE1 mRNA
CTD
PMID:24136188
NCBI chr 5:14,488,784...14,515,405
Ensembl chr 5:9,705,970...9,732,517
G
Adipor2
adiponectin receptor 2
decreases expression
EXP
valdecoxib results in decreased expression of ADIPOR2 mRNA
CTD
PMID:24136188
NCBI chr 4:154,195,440...154,261,141
Ensembl chr 4:152,524,623...152,559,355
G
Adrm1
ADRM1 26S proteasome ubiquitin receptor
increases expression
EXP
valdecoxib results in increased expression of ADRM1 mRNA
CTD
PMID:24136188
NCBI chr 3:187,643,043...187,647,805
Ensembl chr 3:167,265,296...167,270,195
G
Agxt
alanine--glyoxylate aminotransferase
decreases expression
EXP
valdecoxib results in decreased expression of AGXT mRNA
CTD
PMID:24136188
NCBI chr 9:101,122,793...101,132,746
Ensembl chr 9:93,675,384...93,685,336
G
Ahsa1
activator of Hsp90 ATPase activity 1
increases expression
EXP
valdecoxib results in increased expression of AHSA1 mRNA
CTD
PMID:24136188
NCBI chr 6:106,913,296...106,921,347
Ensembl chr 6:106,913,530...106,921,345
G
Aig1
androgen-induced 1
increases expression
EXP
valdecoxib results in increased expression of AIG1 mRNA
CTD
PMID:24136188
NCBI chr 1:8,046,430...8,269,276
Ensembl chr 1:8,046,430...8,269,084
G
Akap8l
A-kinase anchoring protein 8 like
decreases expression
EXP
valdecoxib results in decreased expression of AKAP8L mRNA
CTD
PMID:24136188
NCBI chr 7:11,983,215...12,012,843
Ensembl chr 7:11,332,672...11,362,275
G
Akr1c1
aldo-keto reductase family 1, member C1
decreases expression
EXP
valdecoxib results in decreased expression of AKR1C1 mRNA
CTD
PMID:24136188
NCBI chr17:70,720,397...70,747,285
Ensembl chr17:65,810,475...65,837,326
G
Akr7a3
aldo-keto reductase family 7 member A3
increases expression
EXP
valdecoxib results in increased expression of AKR7A3 mRNA
CTD
PMID:24136188
NCBI chr 5:156,876,721...156,884,599
Ensembl chr 5:151,584,479...151,601,394
G
Alas1
5'-aminolevulinate synthase 1
increases expression
EXP
valdecoxib results in increased expression of ALAS1 mRNA
CTD
PMID:24136188
NCBI chr 8:115,755,238...115,768,642
Ensembl chr 8:106,876,514...106,889,917
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
increases expression
EXP
valdecoxib results in increased expression of ALDH1A1 mRNA
CTD
PMID:24136188
NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:218,042,127...218,152,961
G
Aldh1b1
aldehyde dehydrogenase 1 family, member B1
decreases expression
EXP
valdecoxib results in decreased expression of ALDH1B1 mRNA
CTD
PMID:24136188
NCBI chr 5:64,859,000...64,864,008
Ensembl chr 5:60,063,225...60,068,378
G
Als2cl
ALS2 C-terminal like
increases expression
EXP
valdecoxib results in increased expression of ALS2CL mRNA
CTD
PMID:24136188
NCBI chr 8:110,863,753...110,884,434
Ensembl chr 8:110,864,975...110,884,419
G
Ankle2
ankyrin repeat and LEM domain containing 2
increases expression
EXP
valdecoxib results in increased expression of ANKLE2 mRNA
CTD
PMID:24136188
NCBI chr12:52,077,863...52,110,775
Ensembl chr12:46,417,759...46,500,514
G
Anxa7
annexin A7
increases expression
EXP
valdecoxib results in increased expression of ANXA7 mRNA
CTD
PMID:24136188
NCBI chr15:3,869,180...3,897,827
Ensembl chr15:3,821,845...3,849,385
G
Ap2m1
adaptor related protein complex 2 subunit mu 1
increases expression
EXP
valdecoxib results in increased expression of AP2M1 mRNA
CTD
PMID:24136188
NCBI chr11:93,859,690...93,868,600
Ensembl chr11:80,328,041...80,364,140
G
Apeg3
antisense paternally expressed gene 3
increases expression
EXP
valdecoxib results in increased expression of APEG3 mRNA
CTD
PMID:24136188
NCBI chr 1:67,121,402...67,122,333
Ensembl chr 1:67,121,900...67,122,181 Ensembl chr 1:67,121,900...67,122,181
G
Aplp2
amyloid beta precursor like protein 2
decreases expression
EXP
valdecoxib results in decreased expression of APLP2 mRNA
CTD
PMID:24136188
NCBI chr 8:37,857,407...37,920,487
Ensembl chr 8:29,599,230...29,661,855
G
Apmap
adipocyte plasma membrane associated protein
decreases expression
EXP
valdecoxib results in decreased expression of APMAP mRNA
CTD
PMID:24136188
NCBI chr 3:139,409,021...139,437,296
Ensembl chr 3:139,409,022...139,437,341
G
Apoa4
apolipoprotein A4
decreases expression
EXP
valdecoxib results in decreased expression of APOA4 mRNA
CTD
PMID:24136188
NCBI chr 8:55,435,779...55,438,160
Ensembl chr 8:46,539,082...46,541,469
G
Apob
apolipoprotein B
decreases expression
EXP
valdecoxib results in decreased expression of APOB mRNA
CTD
PMID:24136188
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:30,844,368...30,892,497
G
Apoc4
apolipoprotein C4
decreases expression
EXP
valdecoxib results in decreased expression of APOC4 mRNA
CTD
PMID:24136188
NCBI chr 1:79,335,745...79,339,942
Ensembl chr 1:79,335,745...79,339,981
G
App
amyloid beta precursor protein
increases expression
EXP
valdecoxib results in increased expression of APP mRNA
CTD
PMID:24136188
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561
G
Aqp9
aquaporin 9
decreases expression
EXP
valdecoxib results in decreased expression of AQP9 mRNA
CTD
PMID:24136188
NCBI chr 8:80,678,027...80,718,273
Ensembl chr 8:71,797,234...71,837,395
G
Arhgap8
Rho GTPase activating protein 8
increases expression
EXP
valdecoxib results in increased expression of ARHGAP8 mRNA
CTD
PMID:24136188
NCBI chr 7:115,842,223...115,902,094
Ensembl chr 7:115,850,654...115,902,093
G
Arhgef19
Rho guanine nucleotide exchange factor 19
decreases expression
EXP
valdecoxib results in decreased expression of ARHGEF19 mRNA
CTD
PMID:24136188
NCBI chr 5:153,536,038...153,554,203
Ensembl chr 5:153,536,013...153,554,203
G
Arl6ip1
ARL6 interacting reticulophagy regulator 1
decreases expression
EXP
valdecoxib results in decreased expression of ARL6IP1 mRNA
CTD
PMID:24136188
NCBI chr 1:181,864,717...181,874,232
Ensembl chr 1:172,430,489...172,439,994
G
Arnt
aryl hydrocarbon receptor nuclear translocator
decreases expression
EXP
valdecoxib results in decreased expression of ARNT mRNA
CTD
PMID:24136188
NCBI chr 2:185,686,703...185,745,546
Ensembl chr 2:182,997,736...183,056,580
G
Arpp19
cAMP-regulated phosphoprotein 19
increases expression
EXP
valdecoxib results in increased expression of ARPP19 mRNA
CTD
PMID:24136188
NCBI chr 8:84,660,166...84,683,012
Ensembl chr 8:75,779,523...75,802,452 Ensembl chr 8:75,779,523...75,802,452
G
Asb1
ankyrin repeat and SOCS box-containing 1
decreases expression
EXP
valdecoxib results in decreased expression of ASB1 mRNA
CTD
PMID:24136188
NCBI chr 9:99,566,852...99,588,321
Ensembl chr 9:92,120,306...92,136,376
G
Asnsd1
asparagine synthetase domain containing 1
increases expression
EXP
valdecoxib results in increased expression of ASNSD1 mRNA
CTD
PMID:24136188
NCBI chr 9:55,618,799...55,631,064
Ensembl chr 9:48,126,808...48,139,073
G
Ass1
argininosuccinate synthase 1
decreases expression
EXP
valdecoxib results in decreased expression of ASS1 mRNA
CTD
PMID:24136188
NCBI chr 3:35,144,765...35,194,632
Ensembl chr 3:14,747,368...14,796,903
G
Atg4d
autophagy related 4D, cysteine peptidase
increases expression
EXP
valdecoxib results in increased expression of ATG4D mRNA
CTD
PMID:24136188
NCBI chr 8:19,807,733...19,817,321
Ensembl chr 8:19,807,766...19,817,321
G
Atic
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
increases expression
EXP
valdecoxib results in increased expression of ATIC mRNA
CTD
PMID:24136188
NCBI chr 9:80,614,311...80,634,360
Ensembl chr 9:73,164,846...73,184,889
G
Atp1a1
ATPase Na+/K+ transporting subunit alpha 1
decreases expression
EXP
valdecoxib results in decreased expression of ATP1A1 mRNA
CTD
PMID:24136188
NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:189,020,722...189,048,837
G
Atp2b2
ATPase plasma membrane Ca2+ transporting 2
decreases expression
EXP
valdecoxib results in decreased expression of ATP2B2 mRNA
CTD
PMID:24136188
NCBI chr 4:148,450,207...148,763,653
Ensembl chr 4:146,896,332...147,140,665
G
Atp6v1g1
ATPase H+ transporting V1 subunit G1
increases expression
EXP
valdecoxib results in increased expression of ATP6V1G1 mRNA
CTD
PMID:24136188
NCBI chr 5:76,961,462...76,967,642
Ensembl chr 5:76,961,499...76,969,463
G
Atrn
attractin
decreases expression
EXP
valdecoxib results in decreased expression of ATRN mRNA
CTD
PMID:24136188
NCBI chr 3:138,563,271...138,697,360
Ensembl chr 3:118,110,229...118,244,322
G
Aup1
AUP1, lipid droplet regulating VLDL assembly factor
increases expression
EXP
valdecoxib results in increased expression of AUP1 mRNA
CTD
PMID:24136188
NCBI chr 4:117,118,035...117,121,063
Ensembl chr 4:115,560,261...115,563,346
G
Avpr1a
arginine vasopressin receptor 1A
decreases expression
EXP
valdecoxib results in decreased expression of AVPR1A mRNA
CTD
PMID:24136188
NCBI chr 7:59,999,743...60,003,667
Ensembl chr 7:58,114,284...58,122,215
G
Baz1a
bromodomain adjacent to zinc finger domain, 1A
increases expression
EXP
valdecoxib results in increased expression of BAZ1A mRNA
CTD
PMID:24136188
NCBI chr 6:78,124,872...78,247,672
Ensembl chr 6:72,389,703...72,512,459
G
Bbc3
Bcl-2 binding component 3
increases expression
EXP
valdecoxib results in increased expression of BBC3 mRNA
CTD
PMID:24136188
NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:77,014,543...77,022,509
G
Bbox1
gamma-butyrobetaine hydroxylase 1
decreases expression
EXP
valdecoxib results in decreased expression of BBOX1 mRNA
CTD
PMID:24136188
NCBI chr 3:117,277,226...117,326,383
Ensembl chr 3:96,822,655...96,871,458
G
Bcar3
BCAR3 adaptor protein, NSP family member
increases expression
EXP
valdecoxib results in increased expression of BCAR3 mRNA
CTD
PMID:24136188
NCBI chr 2:213,209,907...213,323,305
Ensembl chr 2:210,525,260...210,638,798
G
Bcl6b
BCL6B, transcription repressor
decreases expression
EXP
valdecoxib results in decreased expression of BCL6B mRNA
CTD
PMID:24136188
NCBI chr10:55,439,566...55,444,631
Ensembl chr10:54,940,909...54,945,974
G
Bhmt
betaine-homocysteine S-methyltransferase
decreases expression
EXP
valdecoxib results in decreased expression of BHMT mRNA
CTD
PMID:24136188
NCBI chr 2:26,594,852...26,614,429
Ensembl chr 2:24,859,873...24,879,742
G
Blvrb
biliverdin reductase B
increases expression
EXP
valdecoxib results in increased expression of BLVRB mRNA
CTD
PMID:24136188
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
G
Bmf
Bcl2 modifying factor
decreases expression
EXP
valdecoxib results in decreased expression of BMF mRNA
CTD
PMID:24136188
NCBI chr 3:125,953,466...125,974,087
Ensembl chr 3:105,499,538...105,520,145
G
Bmp1
bone morphogenetic protein 1
decreases expression
EXP
valdecoxib results in decreased expression of BMP1 mRNA
CTD
PMID:24136188
NCBI chr15:51,961,310...52,005,597
Ensembl chr15:45,551,603...45,595,776
G
Bnip3
BCL2 interacting protein 3
increases expression
EXP
valdecoxib results in increased expression of BNIP3 mRNA
CTD
PMID:24136188
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:193,708,167...193,725,359
G
Bola1
bolA family member 1
increases expression
EXP
valdecoxib results in increased expression of BOLA1 mRNA
CTD
PMID:24136188
NCBI chr 2:183,758,515...183,771,445
Ensembl chr 2:183,758,441...183,781,576
G
Bpgm
bisphosphoglycerate mutase
decreases expression
EXP
valdecoxib results in decreased expression of BPGM mRNA
CTD
PMID:24136188
NCBI chr 4:64,106,809...64,135,749
Ensembl chr 4:63,140,018...63,168,581
G
C1qtnf1
C1q and TNF related 1
increases expression
EXP
valdecoxib results in increased expression of C1QTNF1 mRNA
CTD
PMID:24136188
NCBI chr10:104,159,021...104,180,253
Ensembl chr10:103,660,327...103,681,660
G
C20h6orf89
similar to human chromosome 6 open reading frame 89
increases expression
EXP
valdecoxib results in increased expression of C20H6ORF89 mRNA
CTD
PMID:24136188
NCBI chr20:7,322,483...7,362,054
Ensembl chr20:7,322,442...7,357,612
G
C8h15orf39
similar to human chromosome 15 open reading frame 39
increases expression
EXP
valdecoxib results in increased expression of C8H15ORF39 mRNA
CTD
PMID:24136188
NCBI chr 8:57,646,324...57,655,896
Ensembl chr 8:57,645,756...57,655,941
G
Cacybp
calcyclin binding protein
increases expression
EXP
valdecoxib results in increased expression of CACYBP mRNA
CTD
PMID:24136188
NCBI chr13:74,970,917...74,981,298
Ensembl chr13:72,437,490...72,450,177
G
Cadm1
cell adhesion molecule 1
increases expression
EXP
valdecoxib results in increased expression of CADM1 mRNA
CTD
PMID:24136188
NCBI chr 8:56,744,374...57,075,264
Ensembl chr 8:47,847,325...48,182,833
G
Car14
carbonic anhydrase 14
decreases expression
EXP
valdecoxib results in decreased expression of CAR14 mRNA
CTD
PMID:24136188
NCBI chr 2:186,131,196...186,138,164
Ensembl chr 2:183,441,667...183,449,693
G
Car2
carbonic anhydrase 2
multiple interactions
ISO
valdecoxib binds to and results in decreased activity of CA2 protein
CTD
PMID:17826101
NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:86,741,626...86,756,818
G
Car3
carbonic anhydrase 3
multiple interactions decreases expression
ISO EXP
valdecoxib binds to and results in decreased activity of CA3 protein valdecoxib results in decreased expression of CAR3 mRNA
CTD
PMID:17826101 PMID:24136188
NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:86,770,420...86,784,280
G
Car5a
carbonic anhydrase 5A
decreases expression
EXP
valdecoxib results in decreased expression of CAR5A mRNA
CTD
PMID:24136188
NCBI chr19:66,881,678...66,911,486
Ensembl chr19:49,973,107...50,002,906
G
Car8
carbonic anhydrase 8
increases expression
EXP
valdecoxib results in increased expression of CAR8 mRNA
CTD
PMID:24136188
NCBI chr 5:26,102,767...26,199,819
Ensembl chr 5:21,305,383...21,402,374
G
Cav2
caveolin 2
increases expression
EXP
valdecoxib results in increased expression of CAV2 mRNA
CTD
PMID:24136188
NCBI chr 4:46,582,681...46,590,058
Ensembl chr 4:45,616,712...45,624,244
G
Cavin3
caveolae associated protein 3
increases expression
EXP
valdecoxib results in increased expression of CAVIN3 mRNA
CTD
PMID:24136188
NCBI chr 1:169,238,384...169,239,973
Ensembl chr 1:159,826,549...159,828,161
G
Cbr1
carbonyl reductase 1
increases expression
EXP
valdecoxib results in increased expression of CBR1 mRNA
CTD
PMID:24136188
NCBI chr11:46,346,405...46,348,815
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
G
Cby1
chibby 1, beta catenin antagonist
decreases expression
EXP
valdecoxib results in decreased expression of CBY1 mRNA
CTD
PMID:24136188
NCBI chr 7:113,097,220...113,103,831
G
Ccdc28a
coiled-coil domain containing 28A
increases expression
EXP
valdecoxib results in increased expression of CCDC28A mRNA
CTD
PMID:24136188
NCBI chr 1:12,857,668...12,872,944
Ensembl chr 1:12,857,666...12,873,003
G
Ccdc47
coiled-coil domain containing 47
increases expression
EXP
valdecoxib results in increased expression of CCDC47 mRNA
CTD
PMID:24136188
NCBI chr10:91,630,101...91,648,626
Ensembl chr10:91,130,303...91,148,881
G
Cct2
chaperonin containing TCP1 subunit 2
increases expression
EXP
valdecoxib results in increased expression of CCT2 mRNA
CTD
PMID:24136188
NCBI chr 7:54,578,654...54,591,428
Ensembl chr 7:52,692,725...52,706,944
G
Cct3
chaperonin containing TCP1 subunit 3
increases expression
EXP
valdecoxib results in increased expression of CCT3 mRNA
CTD
PMID:24136188
NCBI chr 2:176,063,529...176,088,180
Ensembl chr 2:173,765,698...173,790,757
G
Cct4
chaperonin containing TCP1 subunit 4
increases expression
EXP
valdecoxib results in increased expression of CCT4 mRNA
CTD
PMID:24136188
NCBI chr14:101,193,057...101,205,935
Ensembl chr14:96,991,859...97,005,267
G
Cct5
chaperonin containing TCP1 subunit 5
increases expression
EXP
valdecoxib results in increased expression of CCT5 mRNA
CTD
PMID:24136188
NCBI chr 2:84,302,621...84,313,773
Ensembl chr 2:82,590,630...82,602,930
G
Cct6a
chaperonin containing TCP1 subunit 6A
increases expression
EXP
valdecoxib results in increased expression of CCT6A mRNA
CTD
PMID:24136188
NCBI chr12:32,508,842...32,519,072
Ensembl chr12:26,872,574...26,883,337
G
Cct7
chaperonin containing TCP1 subunit 7
increases expression
EXP
valdecoxib results in increased expression of CCT7 mRNA
CTD
PMID:24136188
NCBI chr 4:119,546,730...119,563,973
Ensembl chr 4:117,989,232...118,006,580
G
Cct8
chaperonin containing TCP1 subunit 8
increases expression
EXP
valdecoxib results in increased expression of CCT8 mRNA
CTD
PMID:24136188
NCBI chr11:26,710,370...26,722,079
Ensembl chr11:26,710,370...26,722,079
G
Cd1d1
CD1d1 molecule
decreases expression
EXP
valdecoxib results in decreased expression of CD1D1 mRNA
CTD
PMID:24136188
NCBI chr 2:174,721,522...174,725,029
Ensembl chr 2:172,423,582...172,427,089
G
Cd81
Cd81 molecule
decreases expression
EXP
valdecoxib results in decreased expression of CD81 mRNA
CTD
PMID:24136188
NCBI chr 1:207,665,274...207,681,094
Ensembl chr 1:198,241,484...198,251,660
G
Cd99l2
CD99 molecule-like 2
decreases expression
EXP
valdecoxib results in decreased expression of CD99L2 mRNA
CTD
PMID:24136188
NCBI chr15:6,861,242...6,906,838
G
Cdip1
cell death-inducing p53 target 1
decreases expression
EXP
valdecoxib results in decreased expression of CDIP1 mRNA
CTD
PMID:24136188
NCBI chr10:11,278,213...11,303,415
Ensembl chr10:10,774,705...10,796,980
G
Cdkn2aip
CDKN2A interacting protein
increases expression
EXP
valdecoxib results in increased expression of CDKN2AIP mRNA
CTD
PMID:24136188
NCBI chr16:44,536,147...44,546,216
Ensembl chr16:44,536,234...44,540,033
G
Cdkn3
cyclin-dependent kinase inhibitor 3
decreases expression
EXP
valdecoxib results in decreased expression of CDKN3 mRNA
CTD
PMID:24136188
NCBI chr15:22,502,299...22,513,725
Ensembl chr15:20,022,664...20,033,945
G
Cdo1
cysteine dioxygenase type 1
decreases expression
EXP
valdecoxib results in decreased expression of CDO1 mRNA
CTD
PMID:24136188
NCBI chr18:39,432,473...39,447,253
Ensembl chr18:39,432,474...39,447,296
G
Cebpa
CCAAT/enhancer binding protein alpha
decreases expression
EXP
valdecoxib results in decreased expression of CEBPA mRNA
CTD
PMID:24136188
NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:87,759,433...87,762,412
G
Cela1
chymotrypsin like elastase 1
decreases expression
EXP
valdecoxib results in decreased expression of CELA1 mRNA
CTD
PMID:24136188
NCBI chr 7:131,773,161...131,786,300
Ensembl chr 7:131,742,002...131,786,285
G
Cep83
centrosomal protein 83
increases expression
EXP
valdecoxib results in increased expression of CEP83 mRNA
CTD
PMID:24136188
NCBI chr 7:31,167,198...31,276,513
Ensembl chr 7:29,280,419...29,389,574
G
Ces2h
carboxylesterase 2H
increases expression
EXP
valdecoxib results in increased expression of CES2 mRNA
CTD
PMID:24136188
NCBI chr19:49,884,164...49,898,764
Ensembl chr19:32,974,242...32,988,830
G
Chchd6
coiled-coil-helix-coiled-coil-helix domain containing 6
increases expression
EXP
valdecoxib results in increased expression of CHCHD6 mRNA
CTD
PMID:24136188
NCBI chr 4:123,360,729...123,581,429
Ensembl chr 4:121,792,717...122,024,216
G
Chdh
choline dehydrogenase
decreases expression
EXP
valdecoxib results in decreased expression of CHDH mRNA
CTD
PMID:24136188
NCBI chr16:5,199,738...5,232,067
Ensembl chr16:5,194,269...5,225,537
G
Chmp4c
charged multivesicular body protein 4C
increases expression
EXP
valdecoxib results in increased expression of CHMP4C mRNA
CTD
PMID:24136188
NCBI chr 2:93,299,152...93,336,075
Ensembl chr 2:91,388,530...91,428,668
G
Chordc1
cysteine and histidine rich domain containing 1
increases expression
EXP
valdecoxib results in increased expression of CHORDC1 mRNA
CTD
PMID:24136188
NCBI chr 8:23,650,721...23,674,786
Ensembl chr 8:15,374,471...15,399,162
G
Chtf8
chromosome transmission fidelity factor 8
increases expression
EXP
valdecoxib results in increased expression of CHTF8 mRNA
CTD
PMID:24136188
NCBI chr19:51,691,776...51,702,076
Ensembl chr19:34,781,856...34,792,578
G
Ciao2b
cytosolic iron-sulfur assembly component 2B
increases expression
EXP
valdecoxib results in increased expression of CIAO2B mRNA
CTD
PMID:24136188
NCBI chr19:344,194...346,068
Ensembl chr19:344,203...346,068
G
Cidec
cell death-inducing DFFA-like effector c
decreases expression
EXP
valdecoxib results in decreased expression of CIDEC mRNA
CTD
PMID:24136188
NCBI chr 4:148,124,924...148,137,806
Ensembl chr 4:146,569,289...146,582,173
G
Cited2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
decreases expression
EXP
valdecoxib results in decreased expression of CITED2 mRNA
CTD
PMID:24136188
NCBI chr 1:14,132,303...14,134,746
Ensembl chr 1:12,312,160...12,314,897
G
Cldn2
claudin 2
decreases expression
EXP
valdecoxib results in decreased expression of CLDN2 mRNA
CTD
PMID:24136188
NCBI chr X:108,248,383...108,258,847
Ensembl chr X:103,459,780...103,474,838
G
Clec14a
C-type lectin domain containing 14A
increases expression
EXP
valdecoxib results in increased expression of CLEC14A mRNA
CTD
PMID:24136188
NCBI chr 6:81,616,414...81,619,556
Ensembl chr 6:75,881,473...75,884,612
G
Cltb
clathrin, light chain B
increases expression
EXP
valdecoxib results in increased expression of CLTB mRNA
CTD
PMID:24136188
NCBI chr17:10,006,416...10,024,278
Ensembl chr17:10,001,513...10,019,169
G
Cmas
cytidine monophosphate N-acetylneuraminic acid synthetase
increases expression
EXP
valdecoxib results in increased expression of CMAS mRNA
CTD
PMID:24136188
NCBI chr 4:177,449,801...177,468,117
Ensembl chr 4:175,718,808...175,737,125
G
Cmtm6
CKLF-like MARVEL transmembrane domain containing 6
decreases expression
EXP
valdecoxib results in decreased expression of CMTM6 mRNA
CTD
PMID:24136188
NCBI chr 8:123,301,131...123,319,230
Ensembl chr 8:114,422,921...114,441,033
G
Cmya5
cardiomyopathy associated 5
decreases expression
EXP
valdecoxib results in decreased expression of CMYA5 mRNA
CTD
PMID:24136188
NCBI chr 2:24,279,520...24,378,253
Ensembl chr 2:24,279,528...24,378,364
G
Cndp2
carnosine dipeptidase 2
increases expression
EXP
valdecoxib results in increased expression of CNDP2 mRNA
CTD
PMID:24136188
NCBI chr18:80,314,799...80,331,900
Ensembl chr18:78,039,932...78,056,922
G
Cops5
COP9 signalosome subunit 5
increases expression
EXP
valdecoxib results in increased expression of COPS5 mRNA
CTD
PMID:24136188
NCBI chr 5:13,975,198...13,993,391
Ensembl chr 5:9,192,100...9,210,731
G
Coq10a
coenzyme Q10A
decreases expression
EXP
valdecoxib results in decreased expression of COQ10A mRNA
CTD
PMID:24136188
NCBI chr 7:792,089...798,392
Ensembl chr 7:792,089...800,161
G
Cox19
cytochrome c oxidase assembly factor COX19
increases expression
EXP
valdecoxib results in increased expression of COX19 mRNA
CTD
PMID:24136188
NCBI chr12:20,417,389...20,426,868
Ensembl chr12:15,303,551...15,313,014
G
Cp
ceruloplasmin
increases expression
EXP
valdecoxib results in increased expression of CP mRNA
CTD
PMID:24136188
NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:102,439,624...102,498,075
G
Cps1
carbamoyl-phosphate synthase 1
decreases expression
EXP
valdecoxib results in decreased expression of CPS1 mRNA
CTD
PMID:24136188
NCBI chr 9:76,063,863...76,186,739
Ensembl chr 9:68,614,153...68,737,033
G
Crat
carnitine O-acetyltransferase
increases expression
EXP
valdecoxib results in increased expression of CRAT mRNA
CTD
PMID:24136188
NCBI chr 3:34,073,504...34,087,099
Ensembl chr 3:13,675,684...13,689,255
G
Creb3
cAMP responsive element binding protein 3
increases expression
EXP
valdecoxib results in increased expression of CREB3 mRNA
CTD
PMID:24136188
NCBI chr 5:62,613,652...62,619,019
Ensembl chr 5:57,817,832...57,824,390
G
Creg1
cellular repressor of E1A-stimulated genes 1
increases expression
EXP
valdecoxib results in increased expression of CREG1 mRNA
CTD
PMID:24136188
NCBI chr13:80,552,779...80,565,272
Ensembl chr13:78,019,843...78,032,308
G
Crem
cAMP responsive element modulator
decreases expression
EXP
valdecoxib results in decreased expression of CREM mRNA
CTD
PMID:24136188
NCBI chr17:58,932,011...59,001,160
Ensembl chr17:54,239,030...54,305,989
G
Crim1
cysteine rich transmembrane BMP regulator 1
increases expression
EXP
valdecoxib results in increased expression of CRIM1 mRNA
CTD
PMID:24136188
NCBI chr 6:16,695,864...16,870,264
Ensembl chr 6:16,697,829...16,870,259
G
Cryl1
crystallin, lambda 1
increases expression
EXP
valdecoxib results in increased expression of CRYL1 mRNA
CTD
PMID:24136188
NCBI chr15:31,427,011...31,545,997
Ensembl chr15:31,427,054...31,545,997
G
Cryz
crystallin zeta
decreases expression
EXP
valdecoxib results in decreased expression of CRYZ mRNA
CTD
PMID:24136188
NCBI chr 2:243,552,037...243,580,369
Ensembl chr 2:243,552,119...243,579,758
G
Csad
cysteine sulfinic acid decarboxylase
decreases expression
EXP
valdecoxib results in decreased expression of CSAD mRNA
CTD
PMID:24136188
NCBI chr 7:135,187,175...135,216,495
Ensembl chr 7:133,308,574...133,337,615
G
Csnk1d
casein kinase 1, delta
decreases expression
EXP
valdecoxib results in decreased expression of CSNK1D mRNA
CTD
PMID:24136188
NCBI chr10:106,713,497...106,754,953
Ensembl chr10:106,221,992...106,256,614
G
Csrp1
cysteine and glycine-rich protein 1
decreases expression
EXP
valdecoxib results in decreased expression of CSRP1 mRNA
CTD
PMID:24136188
NCBI chr13:47,158,171...47,179,388
Ensembl chr13:47,167,789...47,179,384
G
Ctf1
cardiotrophin 1
increases expression
EXP
valdecoxib results in increased expression of CTF1 mRNA
CTD
PMID:24136188
NCBI chr 1:191,758,512...191,771,259
Ensembl chr 1:182,328,090...182,333,335
G
Cth
cystathionine gamma-lyase
decreases expression
EXP
valdecoxib results in decreased expression of CTH mRNA
CTD
PMID:24136188
NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:246,975,894...247,002,234
G
Ctsd
cathepsin D
increases expression
EXP
valdecoxib results in increased expression of CTSD mRNA
CTD
PMID:24136188
NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:197,527,467...197,539,488
G
Ctsl
cathepsin L
increases expression
EXP
valdecoxib results in increased expression of CTSL mRNA
CTD
PMID:24136188
NCBI chr17:770,104...776,266
Ensembl chr17:764,309...770,548
G
Ctss
cathepsin S
increases expression
EXP
valdecoxib results in increased expression of CTSS mRNA
CTD
PMID:24136188
NCBI chr 2:185,775,316...185,803,440
Ensembl chr 2:183,086,437...183,114,483
G
Cxcl1
C-X-C motif chemokine ligand 1
increases expression
EXP
valdecoxib results in increased expression of CXCL1 mRNA
CTD
PMID:24136188
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,193,365...17,195,215
G
Cyb5a
cytochrome b5 type A
increases expression
EXP
valdecoxib results in increased expression of CYB5A mRNA
CTD
PMID:24136188
NCBI chr18:80,487,923...80,520,544
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
decreases expression
EXP
valdecoxib results in decreased expression of CYP17A1 mRNA
CTD
PMID:24136188
NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:245,535,462...245,541,573
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression decreases activity
EXP ISO
valdecoxib results in increased expression of CYP1A1 mRNA valdecoxib results in decreased activity of CYP1A1 protein
CTD
PMID:24136188 PMID:33814510
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression
EXP
valdecoxib results in increased expression of CYP1A2 mRNA
CTD
PMID:24136188
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases activity
ISO
valdecoxib results in decreased activity of CYP1B1 protein
CTD
PMID:33814510
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:15,342,344...15,350,917
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
increases expression
EXP
valdecoxib results in increased expression of CYP2B1 mRNA
CTD
PMID:24136188
NCBI chr 1:90,646,098...90,669,762
Ensembl chr 1:81,518,408...81,542,052
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
increases expression
EXP
valdecoxib results in increased expression of CYP2C6 mRNA
CTD
PMID:24136188
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
decreases expression
EXP
valdecoxib results in decreased expression of CYP2D4 mRNA
CTD
PMID:24136188
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:113,881,618...113,891,759
G
Cyp2t1
cytochrome P450, family 2, subfamily t, polypeptide 1
decreases expression
EXP
valdecoxib results in decreased expression of CYP2T1 mRNA
CTD
PMID:24136188
NCBI chr 1:82,446,321...82,451,564
Ensembl chr 1:82,446,921...82,451,563
G
Cyp3a18
cytochrome P450, family 3, subfamily a, polypeptide 18
increases expression
EXP
valdecoxib results in increased expression of CYP3A18 mRNA
CTD
PMID:24136188
NCBI chr12:13,994,312...14,044,185
Ensembl chr12:8,880,528...8,930,381
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
increases expression
EXP
valdecoxib results in increased expression of CYP3A23-3A1 mRNA
CTD
PMID:24136188
NCBI chr12:14,369,950...14,398,803
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
increases expression
EXP
valdecoxib results in increased expression of CYP3A9 mRNA
CTD
PMID:24136188
NCBI chr12:21,919,955...21,960,160
Ensembl chr12:16,806,207...16,846,422
G
Cyp4a3
cytochrome P450, family 4, subfamily a, polypeptide 3
increases expression
EXP
valdecoxib results in increased expression of CYP4A3 mRNA
CTD
PMID:24136188
NCBI chr 5:134,334,396...134,352,268
Ensembl chr 5:129,097,926...129,115,463
G
Cyp51
cytochrome P450, family 51
increases expression
EXP
valdecoxib results in increased expression of CYP51 mRNA
CTD
PMID:24136188
NCBI chr 4:30,991,693...31,010,147
Ensembl chr 4:30,036,865...30,055,410 Ensembl chr 6:30,036,865...30,055,410
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
decreases expression
EXP
valdecoxib results in decreased expression of CYP7A1 mRNA
CTD
PMID:24136188
NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:19,376,974...19,386,688
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
decreases expression
EXP
valdecoxib results in decreased expression of CYP8B1 mRNA
CTD
PMID:24136188
NCBI chr 8:130,455,622...130,457,592
Ensembl chr 8:121,557,062...121,580,166
G
Daam1
dishevelled associated activator of morphogenesis 1
decreases expression
EXP
valdecoxib results in decreased expression of DAAM1 mRNA
CTD
PMID:24136188
NCBI chr 6:90,389,544...90,550,114
Ensembl chr 6:90,389,688...90,550,114
G
Dcaf6
DDB1 and CUL4 associated factor 6
increases expression
EXP
valdecoxib results in increased expression of DCAF6 mRNA
CTD
PMID:24136188
NCBI chr13:80,159,282...80,260,510
Ensembl chr13:77,626,307...77,727,512
G
Ddit4
DNA-damage-inducible transcript 4
decreases expression
EXP
valdecoxib results in decreased expression of DDIT4 mRNA
CTD
PMID:24136188
NCBI chr20:28,434,938...28,437,037
Ensembl chr20:27,891,998...27,894,105
G
Dennd2a
DENN domain containing 2A
increases expression
EXP
valdecoxib results in increased expression of DENND2A mRNA
CTD
PMID:24136188
NCBI chr 4:68,233,016...68,332,235
Ensembl chr 4:68,233,958...68,332,105
G
Dennd4c
DENN domain containing 4C
increases expression
EXP
valdecoxib results in increased expression of DENND4C mRNA
CTD
PMID:24136188
NCBI chr 5:101,272,298...101,369,529
Ensembl chr 5:101,272,005...101,368,118
G
Dexi
Dexi homolog
decreases expression
EXP
valdecoxib results in decreased expression of DEXI mRNA
CTD
PMID:24136188
NCBI chr10:5,126,021...5,138,746
Ensembl chr10:5,137,288...5,138,738
G
Dgat2
diacylglycerol O-acyltransferase 2
decreases expression
EXP
valdecoxib results in decreased expression of DGAT2 mRNA
CTD
PMID:24136188
NCBI chr 1:162,866,237...162,896,655
Ensembl chr 1:153,454,080...153,484,428
G
Dgkd
diacylglycerol kinase, delta
increases expression
EXP
valdecoxib results in increased expression of DGKD mRNA
CTD
PMID:24136188
NCBI chr 9:95,964,507...96,055,160
Ensembl chr 9:88,516,715...88,607,345
G
Dmgdh
dimethylglycine dehydrogenase
decreases expression
EXP
valdecoxib results in decreased expression of DMGDH mRNA
CTD
PMID:24136188
NCBI chr 2:26,647,540...26,722,496
Ensembl chr 2:24,912,578...24,987,528
G
Dpt
dermatopontin
decreases expression
EXP
valdecoxib results in decreased expression of DPT mRNA
CTD
PMID:24136188
NCBI chr13:79,656,341...79,684,759
Ensembl chr13:77,123,115...77,151,639
G
Dpyd
dihydropyrimidine dehydrogenase
decreases expression
EXP
valdecoxib results in decreased expression of DPYD mRNA
CTD
PMID:24136188
NCBI chr 2:209,293,902...210,159,777
Ensembl chr 2:206,609,122...207,474,982
G
Dsc2
desmocollin 2
increases expression
EXP
valdecoxib results in increased expression of DSC2 mRNA
CTD
PMID:24136188
NCBI chr18:11,725,466...11,757,591
Ensembl chr18:11,450,390...11,482,392
G
Dusp1
dual specificity phosphatase 1
decreases expression
EXP
valdecoxib results in decreased expression of DUSP1 mRNA
CTD
PMID:24136188
NCBI chr10:17,184,853...17,187,646
G
Dusp5
dual specificity phosphatase 5
increases expression
EXP
valdecoxib results in increased expression of DUSP5 mRNA
CTD
PMID:24136188
NCBI chr 1:262,543,774...262,557,201
Ensembl chr 1:252,538,449...252,551,818
G
Dynll1
dynein light chain LC8-type 1
increases expression
EXP
valdecoxib results in increased expression of DYNLL1 mRNA
CTD
PMID:24136188
NCBI chr12:46,945,291...46,976,867
Ensembl chr12:41,312,367...41,314,741
G
Ebna1bp2
EBNA1 binding protein 2
increases expression
EXP
valdecoxib results in increased expression of EBNA1BP2 mRNA
CTD
PMID:24136188
NCBI chr 5:137,433,534...137,438,100
Ensembl chr 5:132,148,143...132,153,267
G
Ebpl
EBP like
increases expression
EXP
valdecoxib results in increased expression of EBPL mRNA
CTD
PMID:24136188
NCBI chr15:39,684,140...39,707,537
Ensembl chr15:35,508,074...35,531,472
G
Ech1
enoyl-CoA hydratase 1
increases expression
EXP
valdecoxib results in increased expression of ECH1 mRNA
CTD
PMID:24136188
NCBI chr 1:93,241,076...93,248,314
Ensembl chr 1:84,112,751...84,120,795
G
Eci1
enoyl-CoA delta isomerase 1
increases expression
EXP
valdecoxib results in increased expression of ECI1 mRNA
CTD
PMID:24136188
NCBI chr10:13,961,250...13,974,595
Ensembl chr10:13,456,563...13,470,061
G
Ecpas
Ecm29 proteasome adaptor and scaffold
increases expression
EXP
valdecoxib results in increased expression of ECPAS mRNA
CTD
PMID:24136188
NCBI chr 5:78,398,449...78,509,077
Ensembl chr 5:73,604,533...73,713,860
G
Edem1
ER degradation enhancing alpha-mannosidase like protein 1
decreases expression
EXP
valdecoxib results in decreased expression of EDEM1 mRNA
CTD
PMID:24136188
NCBI chr 4:143,350,989...143,385,693
Ensembl chr 4:141,797,701...141,829,717
G
Efna1
ephrin A1
increases expression
EXP
valdecoxib results in increased expression of EFNA1 mRNA
CTD
PMID:24136188
NCBI chr 2:176,979,434...176,988,675
Ensembl chr 2:174,681,682...174,690,866
G
Egfr
epidermal growth factor receptor
decreases expression
EXP
valdecoxib results in decreased expression of EGFR mRNA
CTD
PMID:24136188
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382
G
Egr1
early growth response 1
increases expression
EXP
valdecoxib results in increased expression of EGR1 mRNA
CTD
PMID:24136188
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
G
Eif1ax
eukaryotic translation initiation factor 1A, X-linked
increases expression
EXP
valdecoxib results in increased expression of EIF1AX mRNA
CTD
PMID:24136188
NCBI chr X:35,498,698...35,513,402
Ensembl chr X:35,498,517...35,513,335
G
Eif2a
eukaryotic translation initiation factor 2A
increases expression
EXP
valdecoxib results in increased expression of EIF2A mRNA
CTD
PMID:24136188
NCBI chr 2:144,911,247...144,944,705
Ensembl chr 2:142,761,416...142,795,068
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
decreases expression
EXP
valdecoxib results in decreased expression of EIF2AK3 mRNA
CTD
PMID:24136188
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:102,805,510...102,866,911
G
Eif3a
eukaryotic translation initiation factor 3, subunit A
decreases expression
EXP
valdecoxib results in decreased expression of EIF3A mRNA
CTD
PMID:24136188
NCBI chr 1:269,888,730...269,925,785
Ensembl chr 1:259,902,680...259,932,976
G
Eif4g1
eukaryotic translation initiation factor 4 gamma 1
increases expression
EXP
valdecoxib results in increased expression of EIF4G1 mRNA
CTD
PMID:24136188
NCBI chr11:93,726,322...93,746,387
Ensembl chr11:80,221,919...80,241,941
G
Eif5
eukaryotic translation initiation factor 5
increases expression
EXP
valdecoxib results in increased expression of EIF5 mRNA
CTD
PMID:24136188
NCBI chr 6:130,589,162...130,597,656
Ensembl chr 6:130,589,143...130,597,656
G
Elovl5
ELOVL fatty acid elongase 5
decreases expression
EXP
valdecoxib results in decreased expression of ELOVL5 mRNA
CTD
PMID:24136188
NCBI chr 8:87,671,164...87,737,618
Ensembl chr 8:78,790,846...78,857,284
G
Elovl6
ELOVL fatty acid elongase 6
decreases expression
EXP
valdecoxib results in decreased expression of ELOVL6 mRNA
CTD
PMID:24136188
NCBI chr 2:220,738,095...220,845,528
Ensembl chr 2:218,063,804...218,171,186
G
Enpep
glutamyl aminopeptidase
decreases expression
EXP
valdecoxib results in decreased expression of ENPEP mRNA
CTD
PMID:24136188
NCBI chr 2:220,456,258...220,526,218
Ensembl chr 2:217,782,005...217,851,947
G
Epb41l5
erythrocyte membrane protein band 4.1 like 5
increases expression
EXP
valdecoxib results in increased expression of EPB41L5 mRNA
CTD
PMID:24136188
NCBI chr13:33,221,705...33,321,400
Ensembl chr13:30,669,764...30,768,360
G
Ephx1
epoxide hydrolase 1
increases expression
EXP
valdecoxib results in increased expression of EPHX1 mRNA
CTD
PMID:24136188
NCBI chr13:95,246,079...95,275,852
Ensembl chr13:92,714,315...92,790,235
G
Errfi1
ERBB receptor feedback inhibitor 1
decreases expression
EXP
valdecoxib results in decreased expression of ERRFI1 mRNA
CTD
PMID:24136188
NCBI chr 5:166,606,841...166,620,124
Ensembl chr 5:161,323,998...161,337,282
G
Ethe1
ETHE1, persulfide dioxygenase
decreases expression
EXP
valdecoxib results in decreased expression of ETHE1 mRNA
CTD
PMID:24136188
NCBI chr 1:89,311,948...89,327,000
Ensembl chr 1:80,183,894...80,199,052
G
Etv3
ETS variant transcription factor 3
increases expression
EXP
valdecoxib results in increased expression of ETV3 mRNA
CTD
PMID:24136188
NCBI chr 2:175,263,389...175,278,217
Ensembl chr 2:172,965,588...172,980,314
G
Exo5
exonuclease 5
increases expression
EXP
valdecoxib results in increased expression of EXO5 mRNA
CTD
PMID:24136188
NCBI chr 5:134,494,440...134,497,757
Ensembl chr 5:134,493,829...134,497,772
G
Extl1
exostosin-like glycosyltransferase 1
decreases expression
EXP
valdecoxib results in decreased expression of EXTL1 mRNA
CTD
PMID:24136188
NCBI chr 5:151,857,629...151,872,830
Ensembl chr 5:146,573,912...146,589,115
G
Faah
fatty acid amide hydrolase
decreases expression
EXP
valdecoxib results in decreased expression of FAAH mRNA
CTD
PMID:24136188
NCBI chr 5:134,716,545...134,735,396
Ensembl chr 5:129,479,824...129,498,677
G
Fabp5
fatty acid binding protein 5
decreases expression
EXP
valdecoxib results in decreased expression of FABP5 mRNA
CTD
PMID:24136188
NCBI chr 2:93,672,451...93,676,186
Ensembl chr 2:91,765,056...91,853,773
G
Fads2
fatty acid desaturase 2
decreases expression
EXP
valdecoxib results in decreased expression of FADS2 mRNA
CTD
PMID:24136188
NCBI chr 1:216,132,277...216,172,190
Ensembl chr 1:206,708,783...206,748,789
G
Fam117b
family with sequence similarity 117, member B
decreases expression
EXP
valdecoxib results in decreased expression of FAM117B mRNA
CTD
PMID:24136188
NCBI chr 9:68,834,334...68,902,543
Ensembl chr 9:61,340,249...61,408,483
G
Fam136a
family with sequence similarity 136, member A
increases expression
EXP
valdecoxib results in increased expression of FAM136A mRNA
CTD
PMID:24136188
NCBI chr 4:120,362,563...120,368,479
Ensembl chr 4:118,805,127...118,811,047
G
Fam210b
family with sequence similarity 210, member B
decreases expression
EXP
valdecoxib results in decreased expression of FAM210B mRNA
CTD
PMID:24136188
NCBI chr 3:161,118,228...161,128,400
Ensembl chr 3:161,118,239...161,128,397
G
Fam3a
FAM3 metabolism regulating signaling molecule A
increases expression
EXP
valdecoxib results in increased expression of FAM3A mRNA
CTD
PMID:24136188
NCBI chr X:157,317,993...157,326,640
Ensembl chr X:152,165,535...152,175,362
G
Fasn
fatty acid synthase
decreases expression
EXP
valdecoxib results in decreased expression of FASN mRNA
CTD
PMID:24136188
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,072,091...106,090,261
G
Fastkd2
FAST kinase domains 2
increases expression
EXP
valdecoxib results in increased expression of FASTKD2 mRNA
CTD
PMID:24136188
NCBI chr 9:72,659,961...72,681,986
Ensembl chr 9:65,168,228...65,188,174
G
Fbl
fibrillarin
increases expression
EXP
valdecoxib results in increased expression of FBL mRNA
CTD
PMID:24136188
NCBI chr 1:83,469,832...83,478,932
Ensembl chr 1:83,469,832...83,478,932
G
Fdps
farnesyl diphosphate synthase
increases expression
EXP
valdecoxib results in increased expression of FDPS mRNA
CTD
PMID:24136188
NCBI chr 2:176,795,192...176,804,816
Ensembl chr 2:174,486,665...174,507,776
G
Fgf2
fibroblast growth factor 2
multiple interactions affects secretion
ISO
valdecoxib affects the reaction [Lipopolysaccharides results in increased secretion of FGF2 protein] valdecoxib affects the secretion of FGF2 protein
CTD
PMID:24431307
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:120,236,328...120,291,221
G
Fggy
FGGY carbohydrate kinase domain containing
decreases expression
EXP
valdecoxib results in decreased expression of FGGY mRNA
CTD
PMID:24136188
NCBI chr 5:110,398,866...110,786,019
Ensembl chr 5:110,398,863...110,786,017
G
Fjx1
four-jointed box kinase 1
decreases expression
EXP
valdecoxib results in decreased expression of ANKHD1-EIF4EBP3 mRNA
CTD
PMID:24136188
NCBI chr 3:109,229,223...109,231,324
Ensembl chr 3:88,774,220...88,776,321
G
Fkbp3
FKBP prolyl isomerase 3
increases expression
EXP
valdecoxib results in increased expression of FKBP3 mRNA
CTD
PMID:24136188
NCBI chr 6:88,850,137...88,862,542
Ensembl chr 6:83,113,786...83,127,011
G
Fkbp5
FKBP prolyl isomerase 5
increases expression
EXP
valdecoxib results in increased expression of FKBP5 mRNA
CTD
PMID:24136188
NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,457,216...6,541,674
G
Flcn
folliculin
increases expression
EXP
valdecoxib results in increased expression of FLCN mRNA
CTD
PMID:24136188
NCBI chr10:45,088,164...45,107,581
Ensembl chr10:44,588,624...44,607,769
G
Flot1
flotillin 1
increases expression
EXP
valdecoxib results in increased expression of FLOT1 mRNA
CTD
PMID:24136188
NCBI chr20:2,922,662...2,932,906
Ensembl chr20:2,917,137...2,927,978
G
Fmo1
flavin containing dimethylaniline monoxygenase 1
decreases expression
EXP
valdecoxib results in decreased expression of FMO1 mRNA
CTD
PMID:24136188
NCBI chr13:77,715,405...77,747,666
Ensembl chr13:75,182,176...75,214,647
G
Foxa1
forkhead box A1
decreases expression
EXP
valdecoxib results in decreased expression of FOXA1 mRNA
CTD
PMID:24136188
NCBI chr 6:80,838,380...80,871,195
Ensembl chr 6:75,103,503...75,136,188
G
Fzd7
frizzled class receptor 7
increases expression
EXP
valdecoxib results in increased expression of FZD7 mRNA
CTD
PMID:24136188
NCBI chr 9:68,425,538...68,428,357
Ensembl chr 9:60,930,875...60,935,781
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
decreases expression
EXP
valdecoxib results in decreased expression of G6PC1 mRNA
CTD
PMID:24136188
NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,257,668...86,333,804
G
Gaa
alpha glucosidase
increases expression
EXP
valdecoxib results in increased expression of GAA mRNA
CTD
PMID:24136188
NCBI chr10:105,028,106...105,045,365
Ensembl chr10:104,529,747...104,546,836
G
Gabarapl1
GABA type A receptor associated protein like 1
increases expression
EXP
valdecoxib results in increased expression of GABARAPL1 mRNA
CTD
PMID:24136188
NCBI chr 4:164,666,332...164,675,474
Ensembl chr 4:162,980,249...162,989,450
G
Galm
galactose mutarotase
decreases expression
EXP
valdecoxib results in decreased expression of GALM mRNA
CTD
PMID:24136188
NCBI chr 6:20,589,775...20,641,516
Ensembl chr 6:14,837,548...14,889,310
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression
EXP
valdecoxib results in increased expression of GCLC mRNA
CTD
PMID:24136188
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
EXP
valdecoxib results in increased expression of GCLM mRNA
CTD
PMID:24136188
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535
G
Gda
guanine deaminase
increases expression
EXP
valdecoxib results in increased expression of GDA mRNA
CTD
PMID:24136188
NCBI chr 1:228,333,401...228,408,901
Ensembl chr 1:218,906,815...218,982,416
G
Ggcx
gamma-glutamyl carboxylase
decreases expression
EXP
valdecoxib results in decreased expression of GGCX mRNA
CTD
PMID:24136188
NCBI chr 4:106,027,918...106,043,653
Ensembl chr 4:104,469,765...104,487,063
G
Ggh
gamma-glutamyl hydrolase
increases expression
EXP
valdecoxib results in increased expression of GGH mRNA
CTD
PMID:24136188
NCBI chr 5:38,326,747...38,349,655
Ensembl chr 5:33,529,880...33,552,787
G
Ghr
growth hormone receptor
decreases expression
EXP
valdecoxib results in decreased expression of GHR mRNA
CTD
PMID:24136188
NCBI chr 2:54,269,066...54,532,595
Ensembl chr 2:52,542,594...52,804,735
G
Gja1
gap junction protein, alpha 1
increases expression
EXP
valdecoxib results in increased expression of GJA1 mRNA
CTD
PMID:24136188
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:35,755,991...35,768,582
G
Gjb2
gap junction protein, beta 2
increases expression
EXP
valdecoxib results in increased expression of GJB2 mRNA
CTD
PMID:24136188
NCBI chr15:35,375,977...35,393,817
Ensembl chr15:31,260,357...31,278,177
G
Gldc
glycine decarboxylase
decreases expression
EXP
valdecoxib results in decreased expression of GLDC mRNA
CTD
PMID:24136188
NCBI chr 1:237,296,753...237,375,620
Ensembl chr 1:227,883,249...227,962,097
G
Glrx
glutaredoxin
decreases expression
EXP
valdecoxib results in decreased expression of GLRX mRNA
CTD
PMID:24136188
NCBI chr 2:7,073,737...7,083,548
Ensembl chr 2:5,341,885...5,351,680
G
Gls2
glutaminase 2
decreases expression
EXP
valdecoxib results in decreased expression of GLS2 mRNA
CTD
PMID:24136188
NCBI chr 7:1,201,757...1,218,014
Ensembl chr 7:617,288...633,426
G
Glud1
glutamate dehydrogenase 1
decreases expression
EXP
valdecoxib results in decreased expression of GLUD1 mRNA
CTD
PMID:24136188
NCBI chr16:9,646,569...9,680,215
Ensembl chr16:9,640,312...9,673,957
G
Glul
glutamate-ammonia ligase
decreases expression
EXP
valdecoxib results in decreased expression of GLUL mRNA
CTD
PMID:24136188
NCBI chr13:68,519,500...68,585,554
Ensembl chr13:66,025,630...66,035,108
G
Gm2a
ganglioside GM2 activator
decreases expression
EXP
valdecoxib results in decreased expression of GM2A mRNA
CTD
PMID:24136188
NCBI chr10:39,219,221...39,231,756
Ensembl chr10:39,219,243...39,231,757
G
Gnmt
glycine N-methyltransferase
decreases expression
EXP
valdecoxib results in decreased expression of GNMT mRNA
CTD
PMID:24136188
NCBI chr 9:21,752,235...21,756,368
Ensembl chr 9:14,254,675...14,258,434
G
Gns
glucosamine (N-acetyl)-6-sulfatase
decreases expression
EXP
valdecoxib results in decreased expression of GNS mRNA
CTD
PMID:24136188
NCBI chr 7:58,774,625...58,808,650
Ensembl chr 7:56,889,232...56,923,151
G
Golph3l
golgi phosphoprotein 3-like
decreases expression
EXP
valdecoxib results in decreased expression of GOLPH3L mRNA
CTD
PMID:24136188
NCBI chr 2:185,840,879...185,872,037
Ensembl chr 2:183,153,301...183,183,083
G
Got1
glutamic-oxaloacetic transaminase 1
decreases expression
EXP
valdecoxib results in decreased expression of GOT1 mRNA
CTD
PMID:24136188
NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:242,357,306...242,380,633
G
Gpam
glycerol-3-phosphate acyltransferase, mitochondrial
decreases expression
EXP
valdecoxib results in decreased expression of GPAM mRNA
CTD
PMID:24136188
NCBI chr 1:264,111,599...264,176,112
Ensembl chr 1:254,106,331...254,142,639
G
Gpcpd1
glycerophosphocholine phosphodiesterase 1
decreases expression
EXP
valdecoxib results in decreased expression of GPCPD1 mRNA
CTD
PMID:24136188
NCBI chr 3:140,240,574...140,285,469
Ensembl chr 3:119,787,682...119,832,517
G
Gpd1
glycerol-3-phosphate dehydrogenase 1
decreases expression
EXP
valdecoxib results in decreased expression of GPD1 mRNA
CTD
PMID:24136188
NCBI chr 7:132,722,982...132,730,373
Ensembl chr 7:130,844,138...130,851,529
G
Gpld1
glycosylphosphatidylinositol specific phospholipase D1
decreases expression
EXP
valdecoxib results in decreased expression of GPLD1 mRNA
CTD
PMID:24136188
NCBI chr17:40,512,659...40,560,483
Ensembl chr17:40,084,617...40,126,939
G
Gpt2
glutamic--pyruvic transaminase 2
decreases expression
EXP
valdecoxib results in decreased expression of GPT2 mRNA
CTD
PMID:24136188
NCBI chr19:37,700,023...37,734,551
Ensembl chr19:21,517,621...21,560,610
G
Gpx2
glutathione peroxidase 2
increases expression
EXP
valdecoxib results in increased expression of GPX2 mRNA
CTD
PMID:24136188
NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:95,493,589...95,496,877
G
Grpel2
GrpE-like 2, mitochondrial
increases expression
EXP
valdecoxib results in increased expression of GRPEL2 mRNA
CTD
PMID:24136188
NCBI chr18:57,438,168...57,450,408
Ensembl chr18:55,168,209...55,180,180
G
Gsr
glutathione-disulfide reductase
increases expression
EXP
valdecoxib results in increased expression of GSR mRNA
CTD
PMID:24136188
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
G
Gss
glutathione synthetase
increases expression
EXP
valdecoxib results in increased expression of GSS mRNA
CTD
PMID:24136188
NCBI chr 3:164,508,005...164,538,343
Ensembl chr 3:144,047,850...144,078,198
G
Gsta3
glutathione S-transferase alpha 3
increases expression
EXP
valdecoxib results in increased expression of GSTA3 mRNA
CTD
PMID:24136188
NCBI chr 9:31,154,989...31,180,653
Ensembl chr 9:23,658,574...23,684,240
G
Gstm4
glutathione S-transferase mu 4
increases expression
EXP
valdecoxib results in increased expression of GSTM4 mRNA
CTD
PMID:24136188
NCBI chr 2:198,356,114...198,373,487
Ensembl chr 2:195,680,004...195,685,323
G
Gtf2h1
general transcription factor IIH subunit 1
increases expression
EXP
valdecoxib results in increased expression of GTF2H1 mRNA
CTD
PMID:24136188
NCBI chr 1:97,321,417...97,349,455
Ensembl chr 1:97,321,394...97,349,455
G
Hao2
hydroxyacid oxidase 2
decreases expression
EXP
valdecoxib results in decreased expression of HAO2 mRNA
CTD
PMID:24136188
NCBI chr 2:186,200,137...186,232,997
Ensembl chr 2:186,200,504...186,224,425
G
Hcfc2
host cell factor C2
increases expression
EXP
valdecoxib results in increased expression of HCFC2 mRNA
CTD
PMID:24136188
NCBI chr 7:22,875,440...22,907,391
Ensembl chr 7:20,991,017...21,019,801
G
Hdac11
histone deacetylase 11
decreases expression
EXP
valdecoxib results in decreased expression of HDAC11 mRNA
CTD
PMID:24136188
NCBI chr 4:123,645,873...123,667,407
Ensembl chr 4:123,650,157...123,667,405
G
Hdac2
histone deacetylase 2
decreases expression
EXP
valdecoxib results in decreased expression of HDAC2 mRNA
CTD
PMID:24136188
NCBI chr20:42,101,815...42,126,486
Ensembl chr20:40,548,250...40,571,609
G
Hdgf
heparin binding growth factor
increases expression
EXP
valdecoxib results in increased expression of HDGF mRNA
CTD
PMID:24136188
NCBI chr 2:175,668,290...175,677,614
Ensembl chr 2:173,370,465...173,379,747
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
decreases expression
EXP
valdecoxib results in decreased expression of HERPUD1 mRNA
CTD
PMID:24136188
NCBI chr19:10,604,360...10,624,168
Ensembl chr19:10,598,417...10,618,424
G
Hes6
hes family bHLH transcription factor 6
decreases expression
EXP
valdecoxib results in decreased expression of HES6 mRNA
CTD
PMID:24136188
NCBI chr 9:99,449,375...99,451,343
Ensembl chr 9:92,001,841...92,003,559
G
Hibch
3-hydroxyisobutyryl-CoA hydrolase
increases expression
EXP
valdecoxib results in increased expression of HIBCH mRNA
CTD
PMID:24136188
NCBI chr 9:56,082,082...56,161,796
Ensembl chr 9:48,590,099...48,669,824
G
Hikeshi
heat shock protein nuclear import factor hikeshi
increases expression
EXP
valdecoxib results in increased expression of HIKESHI mRNA
CTD
PMID:24136188
NCBI chr 1:153,237,948...153,261,856
Ensembl chr 1:143,825,923...143,849,363
G
Hirip3
HIRA interacting protein 3
increases expression
EXP
valdecoxib results in increased expression of HIRIP3 mRNA
CTD
PMID:24136188
NCBI chr 1:190,903,065...190,905,610
Ensembl chr 1:181,472,056...181,475,079
G
Hist1h4b
histone cluster 1 H4 family member B
decreases expression
EXP
valdecoxib results in decreased expression of HIST1H4B mRNA
CTD
PMID:24136188
NCBI chr17:42,480,467...42,484,912
Ensembl chr17:42,480,313...42,485,370
G
Hlcs
holocarboxylase synthetase
increases expression
EXP
valdecoxib results in increased expression of HLCS mRNA
CTD
PMID:24136188
NCBI chr11:46,925,491...47,123,111
Ensembl chr11:33,455,809...33,624,222
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
increases expression
EXP
valdecoxib results in increased expression of HMGCS1 mRNA
CTD
PMID:24136188
NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:51,649,497...51,667,100
G
Hmgn1
high mobility group nucleosome binding domain 1
increases expression
EXP
valdecoxib results in increased expression of HMGN1 mRNA
CTD
PMID:24136188
NCBI chr11:48,891,813...48,897,732
Ensembl chr11:35,422,328...35,428,254
G
Hmgn2
high mobility group nucleosomal binding domain 2
decreases expression
EXP
valdecoxib results in decreased expression of HMGN2 mRNA
CTD
PMID:24136188
NCBI chr 5:151,475,907...151,479,361
Ensembl chr 5:146,192,126...146,195,521 Ensembl chr16:146,192,126...146,195,521
G
Hmgn3
high mobility group nucleosomal binding domain 3
increases expression
EXP
valdecoxib results in increased expression of HMGN3 mRNA
CTD
PMID:24136188
NCBI chr 8:84,022,493...84,059,329
Ensembl chr 8:84,022,495...84,062,976
G
Hoga1
4-hydroxy-2-oxoglutarate aldolase 1
decreases expression
EXP
valdecoxib results in decreased expression of HOGA1 mRNA
CTD
PMID:24136188
NCBI chr 1:250,806,430...250,833,544
Ensembl chr 1:240,857,126...240,884,568
G
Hsd17b13
hydroxysteroid (17-beta) dehydrogenase 13
decreases expression
EXP
valdecoxib results in decreased expression of HSD17B13 mRNA
CTD
PMID:24136188
NCBI chr14:5,751,697...5,766,809
Ensembl chr14:5,752,132...5,768,166
G
Hsdl2
hydroxysteroid dehydrogenase like 2
increases expression
EXP
valdecoxib results in increased expression of HSDL2 mRNA
CTD
PMID:24136188
NCBI chr 5:79,238,881...79,274,051
Ensembl chr 5:74,443,872...74,479,839
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
increases expression
EXP
valdecoxib results in increased expression of HSP90AA1 mRNA
CTD
PMID:24136188
NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:129,702,383...129,707,268
G
Hsp90ab1
heat shock protein 90 alpha family class B member 1
increases expression
EXP
valdecoxib results in increased expression of HSP90AB1 mRNA
CTD
PMID:24136188
NCBI chr 9:22,930,249...22,935,929
Ensembl chr 9:15,433,691...15,438,488
G
Hspb1
heat shock protein family B (small) member 1
increases expression
EXP
valdecoxib results in increased expression of HSPB1 mRNA
CTD
PMID:24136188
NCBI chr12:26,430,640...26,432,301
Ensembl chr12:20,794,028...20,795,743
G
Hspb8
heat shock protein family B (small) member 8
increases expression
EXP
valdecoxib results in increased expression of HSPB8 mRNA
CTD
PMID:24136188
NCBI chr12:45,835,899...45,866,449
Ensembl chr12:40,176,532...40,191,185
G
Hsph1
heat shock protein family H (Hsp110) member 1
increases expression
EXP
valdecoxib results in increased expression of HSPH1 mRNA
CTD
PMID:24136188
NCBI chr12:10,427,368...10,446,602
Ensembl chr12:5,390,922...5,410,224
G
Htatip2
HIV-1 Tat interactive protein 2
increases expression
EXP
valdecoxib results in increased expression of HTATIP2 mRNA
CTD
PMID:24136188
NCBI chr 1:108,609,424...108,624,810
Ensembl chr 1:99,469,245...99,488,629
G
Hyal3
hyaluronidase 3
decreases expression
EXP
valdecoxib results in decreased expression of HYAL3 mRNA
CTD
PMID:24136188
NCBI chr 8:117,133,028...117,138,663
Ensembl chr 8:108,250,667...108,260,647
G
Ide
insulin degrading enzyme
increases expression
EXP
valdecoxib results in increased expression of IDE mRNA
CTD
PMID:24136188
NCBI chr 1:244,415,495...244,516,925
Ensembl chr 1:234,995,351...235,102,440
G
Idi1
isopentenyl-diphosphate delta isomerase 1
increases expression
EXP
valdecoxib results in increased expression of IDI1 mRNA
CTD
PMID:24136188
NCBI chr17:66,539,761...66,547,524
Ensembl chr17:61,629,594...61,637,357
G
Ifitm3
interferon induced transmembrane protein 3
increases expression
EXP
valdecoxib results in increased expression of IFITM3 mRNA
CTD
PMID:24136188
NCBI chr 1:205,540,649...205,541,758
Ensembl chr 1:196,111,043...196,112,203
G
Ifng
interferon gamma
increases expression
EXP
valdecoxib results in increased expression of IFNG
CTD
PMID:24136188
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Ift25
intraflagellar transport 25
increases expression
EXP
valdecoxib results in increased expression of IFT25 mRNA
CTD
PMID:24136188
NCBI chr 5:127,264,450...127,291,225
Ensembl chr 5:122,035,581...122,062,421
G
Igfbp3
insulin-like growth factor binding protein 3
decreases expression
EXP
valdecoxib results in decreased expression of IGFBP3 mRNA
CTD
PMID:24136188
NCBI chr14:86,270,208...86,277,944
Ensembl chr14:82,056,347...82,064,083
G
Il13ra1
interleukin 13 receptor subunit alpha 1
increases expression
EXP
valdecoxib results in increased expression of IL13RA1 mRNA
CTD
PMID:24136188
NCBI chr X:120,213,670...120,294,777
Ensembl chr X:115,348,860...115,408,681 Ensembl chr11:115,348,860...115,408,681
G
Il6
interleukin 6
increases expression
EXP
valdecoxib results in increased expression of IL6
CTD
PMID:24136188
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Impact
impact RWD domain protein
increases expression
EXP
valdecoxib results in increased expression of IMPACT mRNA
CTD
PMID:24136188
NCBI chr18:4,108,872...4,147,571
Ensembl chr18:4,108,853...4,147,569
G
Inhbc
inhibin subunit beta C
decreases expression
EXP
valdecoxib results in decreased expression of INHBC mRNA
CTD
PMID:24136188
NCBI chr 7:65,069,450...65,082,919
Ensembl chr 7:63,184,142...63,197,630
G
Inhbe
inhibin subunit beta E
decreases expression
EXP
valdecoxib results in decreased expression of INHBE mRNA
CTD
PMID:24136188
NCBI chr 7:65,061,531...65,064,519
Ensembl chr 7:63,176,219...63,179,172
G
Inmt
indolethylamine N-methyltransferase
increases expression
EXP
valdecoxib results in increased expression of INMT mRNA
CTD
PMID:24136188
NCBI chr 4:85,648,459...85,652,755
Ensembl chr 4:84,318,197...84,322,493
G
Insig2
insulin induced gene 2
increases expression
EXP
valdecoxib results in increased expression of INSIG2 mRNA
CTD
PMID:24136188
NCBI chr13:35,025,160...35,052,937
Ensembl chr13:32,473,742...32,494,923
G
Ip6k2
inositol hexakisphosphate kinase 2
decreases expression
EXP
valdecoxib results in decreased expression of IP6K2 mRNA
CTD
PMID:24136188
NCBI chr 8:118,362,154...118,388,668
Ensembl chr 8:109,484,310...109,510,166
G
Ipo4
importin 4
increases expression
EXP
valdecoxib results in increased expression of IPO4 mRNA
CTD
PMID:24136188
NCBI chr15:33,087,321...33,097,241
Ensembl chr15:29,117,365...29,127,285
G
Irak1
interleukin-1 receptor-associated kinase 1
increases expression
EXP
valdecoxib results in increased expression of IRAK1 mRNA
CTD
PMID:24136188
NCBI chr X:156,919,927...156,929,825
Ensembl chr X:151,768,777...151,778,521
G
Islr
immunoglobulin superfamily containing leucine-rich repeat
decreases expression
EXP
valdecoxib results in decreased expression of ISLR mRNA
CTD
PMID:24136188
NCBI chr 8:58,571,155...58,574,128
Ensembl chr 8:58,570,777...58,574,130
G
Isyna1
inositol-3-phosphate synthase 1
increases expression
EXP
valdecoxib results in increased expression of ISYNA1 mRNA
CTD
PMID:24136188
NCBI chr16:18,873,119...18,876,116
Ensembl chr16:18,839,145...18,841,979
G
Ivd
isovaleryl-CoA dehydrogenase
decreases expression
EXP
valdecoxib results in decreased expression of IVD mRNA
CTD
PMID:24136188
NCBI chr 3:126,305,584...126,326,016
Ensembl chr 3:105,851,683...105,872,575
G
Jpt1
Jupiter microtubule associated homolog 1
increases expression
EXP
valdecoxib results in increased expression of JPT1 mRNA
CTD
PMID:24136188
NCBI chr10:100,744,468...100,762,504
Ensembl chr10:100,686,797...100,784,513
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
valdecoxib results in increased expression of JUNB mRNA
CTD
PMID:24136188
NCBI chr19:40,081,126...40,082,910
Ensembl chr19:23,176,294...23,178,035
G
Kcmf1
potassium channel modulatory factor 1
increases expression
EXP
valdecoxib results in increased expression of KCMF1 mRNA
CTD
PMID:24136188
NCBI chr 4:104,888,452...104,950,234
Ensembl chr 4:104,889,847...104,950,234
G
Kcnj8
potassium inwardly-rectifying channel, subfamily J, member 8
increases expression
EXP
valdecoxib results in increased expression of KCNJ8 mRNA
CTD
PMID:24136188
NCBI chr 4:177,240,692...177,246,548
Ensembl chr 4:175,508,912...175,515,603
G
Kdsr
3-ketodihydrosphingosine reductase
decreases expression
EXP
valdecoxib results in decreased expression of KDSR mRNA
CTD
PMID:24136188
NCBI chr13:22,862,117...22,894,118
Ensembl chr13:22,862,117...22,894,108
G
Keap1
Kelch-like ECH-associated protein 1
increases expression
EXP
valdecoxib results in increased expression of KEAP1 mRNA
CTD
PMID:24136188
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:19,768,375...19,777,862
G
Khk
ketohexokinase
decreases expression
EXP
valdecoxib results in decreased expression of KHK mRNA
CTD
PMID:24136188
NCBI chr 6:31,165,246...31,175,779
Ensembl chr 6:25,445,300...25,455,717
G
Kif21a
kinesin family member 21A
increases expression
EXP
valdecoxib results in increased expression of KIF21A mRNA
CTD
PMID:24136188
NCBI chr 7:122,062,523...122,179,051
Ensembl chr 7:122,062,537...122,178,999
G
Klf15
KLF transcription factor 15
decreases expression
EXP
valdecoxib results in decreased expression of KLF15 mRNA
CTD
PMID:24136188
NCBI chr 4:124,522,652...124,535,613
Ensembl chr 4:122,965,807...122,978,374
G
Klhl24
kelch-like family member 24
increases expression
EXP
valdecoxib results in increased expression of KLHL24 mRNA
CTD
PMID:24136188
NCBI chr11:94,348,024...94,382,085
Ensembl chr11:80,846,755...80,877,636
G
Klrg1
killer cell lectin like receptor G1
decreases expression
EXP
valdecoxib results in decreased expression of KLRG1 mRNA
CTD
PMID:24136188
NCBI chr 4:157,127,571...157,139,372
Ensembl chr 4:155,455,495...155,467,424
G
Kmt2a
lysine methyltransferase 2A
increases expression
EXP
valdecoxib results in increased expression of KMT2A mRNA
CTD
PMID:24136188
NCBI chr 8:54,013,547...54,089,219
Ensembl chr 8:45,118,814...45,193,181
G
Krt8
keratin 8
increases expression
EXP
valdecoxib results in increased expression of KRT8 mRNA
CTD
PMID:24136188
NCBI chr 7:135,002,886...135,010,339
Ensembl chr 7:133,124,203...133,131,728
G
Kxd1
KxDL motif containing 1
increases expression
EXP
valdecoxib results in increased expression of KXD1 mRNA
CTD
PMID:24136188
NCBI chr16:18,895,343...18,916,266
Ensembl chr16:18,900,616...18,920,807
G
Kyat1
kynurenine aminotransferase 1
increases expression
EXP
valdecoxib results in increased expression of KYAT1 mRNA
CTD
PMID:24136188
NCBI chr 3:33,857,407...33,891,153
Ensembl chr 3:13,459,591...13,493,355
G
L3hypdh
trans-L-3-hydroxyproline dehydratase
decreases expression
EXP
valdecoxib results in decreased expression of L3HYPDH mRNA
CTD
PMID:24136188
NCBI chr 6:96,372,243...96,383,039
Ensembl chr 6:90,636,310...90,647,106
G
Lama3
laminin subunit alpha 3
decreases expression
EXP
valdecoxib results in decreased expression of LAMA3 mRNA
CTD
PMID:24136188
NCBI chr18:3,797,898...4,033,021
Ensembl chr18:3,523,133...3,751,353
G
Lamtor1
late endosomal/lysosomal adaptor, MAPK and MTOR activator 1
increases expression
EXP
valdecoxib results in increased expression of LAMTOR1 mRNA
CTD
PMID:24136188
NCBI chr 1:156,272,116...156,277,687
Ensembl chr 1:156,272,064...156,291,179
G
Lbh
LBH regulator of WNT signaling pathway
decreases expression
EXP
valdecoxib results in decreased expression of LBH mRNA
CTD
PMID:24136188
NCBI chr 6:28,321,040...28,344,855
Ensembl chr 6:22,568,834...22,593,079
G
Lbp
lipopolysaccharide binding protein
increases expression
EXP
valdecoxib results in increased expression of LBP mRNA
CTD
PMID:24136188
NCBI chr 3:167,373,786...167,400,941
Ensembl chr 3:146,954,015...146,981,586
G
Lcmt1
leucine carboxyl methyltransferase 1
decreases expression
EXP
valdecoxib results in decreased expression of LCMT1 mRNA
CTD
PMID:24136188
NCBI chr 1:187,335,173...187,391,195
Ensembl chr 1:177,904,139...177,960,112
G
Lgals3
galectin 3
increases expression
EXP
valdecoxib results in increased expression of LGALS3 mRNA
CTD
PMID:24136188
NCBI chr15:23,099,795...23,111,731
Ensembl chr15:20,607,692...20,632,025
G
Lgals8
galectin 8
increases expression
EXP
valdecoxib results in increased expression of LGALS8 mRNA
CTD
PMID:24136188
NCBI chr17:62,716,368...62,744,272
Ensembl chr17:58,028,105...58,052,764
G
Lhpp
phospholysine phosphohistidine inorganic pyrophosphate phosphatase
decreases expression
EXP
valdecoxib results in decreased expression of LHPP mRNA
CTD
PMID:24136188
NCBI chr 1:187,403,390...187,494,577
Ensembl chr 1:187,403,433...187,494,578
G
Lipa
lipase A, lysosomal acid type
increases expression
EXP
valdecoxib results in increased expression of LIPA mRNA
CTD
PMID:24136188
NCBI chr 1:241,437,524...241,470,936
Ensembl chr 1:232,024,356...232,057,633
G
Lipc
lipase C, hepatic type
decreases expression
EXP
valdecoxib results in decreased expression of LIPC mRNA
CTD
PMID:24136188
NCBI chr 8:80,390,470...80,516,463
Ensembl chr 8:71,509,635...71,635,464
G
Lmnb1
lamin B1
increases expression
EXP
valdecoxib results in increased expression of LMNB1 mRNA
CTD
PMID:24136188
NCBI chr18:52,373,939...52,413,284
Ensembl chr18:50,175,874...50,214,502
G
Lmo7
LIM domain 7
decreases expression
EXP
valdecoxib results in decreased expression of LMO7 mRNA
CTD
PMID:24136188
NCBI chr15:84,981,689...85,184,554
Ensembl chr15:78,567,023...78,769,783
G
Lpar6
lysophosphatidic acid receptor 6
increases expression
EXP
valdecoxib results in increased expression of LPAR6 mRNA
CTD
PMID:24136188
NCBI chr15:54,826,110...54,827,919
Ensembl chr15:48,416,544...48,422,331
G
Lrat
lecithin retinol acyltransferase
decreases expression
EXP
valdecoxib results in decreased expression of LRAT mRNA
CTD
PMID:24136188
NCBI chr 2:170,562,148...170,571,212
Ensembl chr 2:168,266,877...168,273,619
G
Lrp11
LDL receptor related protein 11
decreases expression
EXP
valdecoxib results in decreased expression of LRP11 mRNA
CTD
PMID:24136188
NCBI chr 1:2,048,307...2,108,115
Ensembl chr 1:2,079,438...2,108,110
G
Lrp3
LDL receptor related protein 3
decreases expression
EXP
valdecoxib results in decreased expression of LRP3 mRNA
CTD
PMID:24136188
NCBI chr 1:96,980,762...96,996,157
Ensembl chr 1:87,844,868...87,859,110
G
Lrp5
LDL receptor related protein 5
decreases expression
EXP
valdecoxib results in decreased expression of LRP5 mRNA
CTD
PMID:24136188
NCBI chr 1:210,243,499...210,346,886
Ensembl chr 1:200,814,250...200,917,581
G
Lrp6
LDL receptor related protein 6
decreases expression
EXP
valdecoxib results in decreased expression of LRP6 mRNA
CTD
PMID:24136188
NCBI chr 4:168,997,937...169,131,716
Ensembl chr 4:167,270,353...167,400,497
G
Lrrc8b
leucine rich repeat containing 8 VRAC subunit B
decreases expression
EXP
valdecoxib results in decreased expression of LRRC8B mRNA
CTD
PMID:24136188
NCBI chr14:4,350,462...4,416,336
Ensembl chr14:4,354,508...4,416,311
G
Lrrfip1
LRR binding FLII interacting protein 1
increases expression
EXP
valdecoxib results in increased expression of LRRFIP1 mRNA
CTD
PMID:24136188
NCBI chr 9:91,592,032...91,720,250
Ensembl chr 9:91,643,197...91,720,250
G
Lss
lanosterol synthase
increases expression
EXP
valdecoxib results in increased expression of LSS mRNA
CTD
PMID:24136188
NCBI chr20:12,090,641...12,118,230
Ensembl chr20:12,092,774...12,118,762
G
Ltbr
lymphotoxin beta receptor
increases expression
EXP
valdecoxib results in increased expression of LTBR mRNA
CTD
PMID:24136188
NCBI chr 4:159,795,115...159,801,571
Ensembl chr 4:158,108,886...158,121,539
G
Luc7l
LUC7-like
increases expression
EXP
valdecoxib results in increased expression of LUC7L mRNA
CTD
PMID:24136188
NCBI chr10:15,777,837...15,811,586
Ensembl chr10:15,273,348...15,303,112
G
Lysmd2
LysM domain containing 2
increases expression
EXP
valdecoxib results in increased expression of LYSMD2 mRNA
CTD
PMID:24136188
NCBI chr 8:76,378,984...76,394,396
Ensembl chr 8:76,379,219...76,394,654
G
Lyst
lysosomal trafficking regulator
decreases expression
EXP
valdecoxib results in decreased expression of LYST mRNA
CTD
PMID:24136188
NCBI chr17:93,225,509...93,427,650
Ensembl chr17:86,241,384...86,443,480
G
Macrod1
mono-ADP ribosylhydrolase 1
decreases expression
EXP
valdecoxib results in decreased expression of MACROD1 mRNA
CTD
PMID:24136188
NCBI chr 1:213,675,413...213,831,571
Ensembl chr 1:204,246,166...204,389,716
G
Mafb
MAF bZIP transcription factor B
decreases expression
EXP
valdecoxib results in decreased expression of MAFB mRNA
CTD
PMID:24136188
NCBI chr 3:169,417,890...169,419,810
Ensembl chr 3:148,998,122...149,000,031
G
Mafk
MAF bZIP transcription factor K
increases expression
EXP
valdecoxib results in increased expression of MAFK mRNA
CTD
PMID:24136188
NCBI chr12:19,948,473...19,970,351
Ensembl chr12:14,833,984...14,837,048 Ensembl chr12:14,833,984...14,837,048
G
Mal2
mal, T-cell differentiation protein 2
increases expression
EXP
valdecoxib results in increased expression of MAL2 mRNA
CTD
PMID:24136188
NCBI chr 7:87,790,239...87,823,219
Ensembl chr 7:85,900,453...85,933,429
G
Malsu1
mitochondrial assembly of ribosomal large subunit 1
increases expression
EXP
valdecoxib results in increased expression of MALSU1 mRNA
CTD
PMID:24136188
NCBI chr 4:78,051,090...78,059,913
Ensembl chr 4:78,051,059...78,059,905
G
Manba
mannosidase beta
increases expression
EXP
valdecoxib results in increased expression of MANBA mRNA
CTD
PMID:24136188
NCBI chr 2:226,583,968...226,676,520
Ensembl chr 2:223,910,432...224,002,983
G
Map2k2
mitogen activated protein kinase kinase 2
increases expression
EXP
valdecoxib results in increased expression of MAP2K2 mRNA
CTD
PMID:24136188
NCBI chr 7:9,241,449...9,264,216
Ensembl chr 7:8,580,905...8,610,243
G
Mapkapk2
MAPK activated protein kinase 2
decreases expression
EXP
valdecoxib results in decreased expression of MAPKAPK2 mRNA
CTD
PMID:24136188
NCBI chr13:45,066,027...45,112,326
Ensembl chr13:42,513,762...42,560,457
G
Marchf2
membrane associated ring-CH-type finger 2
decreases expression
EXP
valdecoxib results in decreased expression of MARCHF2 mRNA
CTD
PMID:24136188
NCBI chr 7:14,480,605...14,507,821
Ensembl chr 7:14,481,761...14,507,794
G
Marchf5
membrane associated ring-CH-type finger 5
increases expression
EXP
valdecoxib results in increased expression of MARCHF5 mRNA
CTD
PMID:24136188
NCBI chr 1:244,343,674...244,365,160
Ensembl chr 1:234,931,271...234,952,632
G
Mcoln1
mucolipin TRP cation channel 1
increases expression
EXP
valdecoxib results in increased expression of MCOLN1 mRNA
CTD
PMID:24136188
NCBI chr12:6,357,851...6,372,151
Ensembl chr12:1,560,359...1,574,252
G
Mdh1
malate dehydrogenase 1
decreases expression
EXP
valdecoxib results in decreased expression of MDH1 mRNA
CTD
PMID:24136188
NCBI chr14:99,831,934...99,847,227
Ensembl chr14:95,630,306...95,645,925
G
Mdm2
MDM2 proto-oncogene
increases expression
EXP
valdecoxib results in increased expression of MDM2 mRNA
CTD
PMID:24136188
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:53,290,664...53,314,915
G
Mdp1
magnesium-dependent phosphatase 1
decreases expression
EXP
valdecoxib results in decreased expression of MDP1 mRNA
CTD
PMID:24136188
NCBI chr15:33,118,944...33,121,817
Ensembl chr15:29,148,994...29,151,905
G
Me1
malic enzyme 1
increases expression
EXP
valdecoxib results in increased expression of ME1 mRNA
CTD
PMID:24136188
NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:87,549,043...87,660,304
G
Meox2
mesenchyme homeobox 2
increases expression
EXP
valdecoxib results in increased expression of MEOX2 mRNA
CTD
PMID:24136188
NCBI chr 6:59,584,025...59,644,722
Ensembl chr 6:53,856,758...53,917,467
G
Mfsd2a
MFSD2 lysolipid transporter A, lysophospholipid
decreases expression
EXP
valdecoxib results in decreased expression of MFSD2A mRNA
CTD
PMID:24136188
NCBI chr 5:140,510,933...140,525,828
Ensembl chr 5:135,225,816...135,240,690
G
Mgat4b
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B
decreases expression
EXP
valdecoxib results in decreased expression of MGAT4B mRNA
CTD
PMID:24136188
NCBI chr10:35,049,421...35,060,307
Ensembl chr10:34,549,433...34,559,229
G
Mgll
monoglyceride lipase
increases expression
EXP
valdecoxib results in increased expression of MGLL mRNA
CTD
PMID:24136188
NCBI chr 4:122,749,436...122,851,440
Ensembl chr 4:121,192,195...121,294,179
G
Mgst2
microsomal glutathione S-transferase 2
increases expression
EXP
valdecoxib results in increased expression of MGST2 mRNA
CTD
PMID:24136188
NCBI chr 2:137,821,787...137,866,664
Ensembl chr 2:135,693,557...135,715,828
G
Mgst3
microsomal glutathione S-transferase 3
decreases expression
EXP
valdecoxib results in decreased expression of MGST3 mRNA
CTD
PMID:24136188
NCBI chr13:82,059,480...82,080,418
Ensembl chr13:79,526,541...79,547,411
G
Mia2
MIA SH3 domain ER export factor 2
decreases expression
EXP
valdecoxib results in decreased expression of MIA2 mRNA
CTD
PMID:24136188
NCBI chr 6:82,522,398...82,620,136
Ensembl chr 6:76,787,508...76,885,211
G
Midn
midnolin
increases expression
EXP
valdecoxib results in increased expression of MIDN mRNA
CTD
PMID:24136188
NCBI chr 7:10,198,761...10,210,563
Ensembl chr 7:9,549,650...9,559,752
G
Mknk2
MAPK interacting serine/threonine kinase 2
decreases expression
EXP
valdecoxib results in decreased expression of MKNK2 mRNA
CTD
PMID:24136188
NCBI chr 7:9,690,385...9,701,527
Ensembl chr 7:9,039,728...9,050,827
G
Mkrn1
makorin ring finger protein 1
decreases expression
EXP
valdecoxib results in decreased expression of MKRN1 mRNA
CTD
PMID:24136188
NCBI chr 4:68,175,908...68,197,216
Ensembl chr 4:68,175,909...68,197,165 Ensembl chr 9:68,175,909...68,197,165
G
Mllt10
MLLT10, histone lysine methyltransferase DOT1L cofactor
increases expression
EXP
valdecoxib results in increased expression of MLLT10 mRNA
CTD
PMID:24136188
NCBI chr17:85,729,964...85,857,791
Ensembl chr17:80,822,556...80,949,345
G
Mmgt1
membrane magnesium transporter 1
increases expression
EXP
valdecoxib results in increased expression of MMGT1 mRNA
CTD
PMID:24136188
NCBI chr X:134,408,463...134,420,798
Ensembl chr X:134,408,466...134,420,729
G
Mospd2
motile sperm domain containing 2
increases expression
EXP
valdecoxib results in increased expression of MOSPD2 mRNA
CTD
PMID:24136188
NCBI chr X:33,052,063...33,105,550
Ensembl chr X:29,420,586...29,462,398
G
Mpc1
mitochondrial pyruvate carrier 1
decreases expression
EXP
valdecoxib results in decreased expression of MPC1 mRNA
CTD
PMID:24136188
NCBI chr 1:54,985,305...54,996,979
Ensembl chr 1:52,437,741...52,449,400
G
Mpc2
mitochondrial pyruvate carrier 2
increases expression
EXP
valdecoxib results in increased expression of MPC2 mRNA
CTD
PMID:24136188
NCBI chr13:77,728,176...77,747,664
Ensembl chr13:77,728,250...77,747,664
G
Mphosph8
M-phase phosphoprotein 8
increases expression
EXP
valdecoxib results in increased expression of MPHOSPH8 mRNA
CTD
PMID:24136188
NCBI chr15:30,800,546...30,828,415
Ensembl chr15:30,686,613...30,828,810
G
Mrpl14
mitochondrial ribosomal protein L14
increases expression
EXP
valdecoxib results in increased expression of MRPL14 mRNA
CTD
PMID:24136188
NCBI chr 9:15,302,840...15,315,195
Ensembl chr 9:15,302,427...15,315,267
G
Mrpl38
mitochondrial ribosomal protein L38
increases expression
EXP
valdecoxib results in increased expression of MRPL38 mRNA
CTD
PMID:24136188
NCBI chr10:101,365,353...101,372,159
Ensembl chr10:101,365,353...101,372,171
G
Mrpl49
mitochondrial ribosomal protein L49
increases expression
EXP
valdecoxib results in increased expression of MRPL49 mRNA
CTD
PMID:24136188
NCBI chr 1:203,346,068...203,350,040
Ensembl chr 1:203,332,481...203,350,049
G
Mrpl51
mitochondrial ribosomal protein L51
increases expression
EXP
valdecoxib results in increased expression of MRPL51 mRNA
CTD
PMID:24136188
NCBI chr 4:159,677,988...159,681,650
Ensembl chr 4:157,992,408...157,995,414
G
Mrpl55
mitochondrial ribosomal protein L55
increases expression
EXP
valdecoxib results in increased expression of MRPL55 mRNA
CTD
PMID:24136188
NCBI chr10:43,988,676...43,991,841
Ensembl chr10:43,988,683...43,991,841
G
Mrps18b
mitochondrial ribosomal protein S18B
increases expression
EXP
valdecoxib results in increased expression of MRPS18B mRNA
CTD
PMID:24136188
NCBI chr20:2,842,978...2,849,065
Ensembl chr20:2,838,030...2,844,260
G
Mrps27
mitochondrial ribosomal protein S27
increases expression
EXP
valdecoxib results in increased expression of MRPS27 mRNA
CTD
PMID:24136188
NCBI chr 2:32,474,178...32,542,741
Ensembl chr 2:30,740,033...30,808,577
G
Msmo1
methylsterol monooxygenase 1
increases expression
EXP
valdecoxib results in increased expression of MSMO1 mRNA
CTD
PMID:24136188
NCBI chr16:29,747,113...29,764,360
Ensembl chr16:24,980,697...24,998,016
G
Mtmr7
myotubularin related protein 7
decreases expression
EXP
valdecoxib results in decreased expression of MTMR7 mRNA
CTD
PMID:24136188
NCBI chr16:51,641,267...51,732,212
Ensembl chr16:51,641,190...51,732,182
G
Mvk
mevalonate kinase
increases expression
EXP
valdecoxib results in increased expression of MVK mRNA
CTD
PMID:24136188
NCBI chr12:47,802,002...47,819,503
Ensembl chr12:42,141,384...42,158,882
G
Myl9
myosin light chain 9
decreases expression
EXP
valdecoxib results in decreased expression of MYL9 mRNA
CTD
PMID:24136188
NCBI chr 3:165,742,020...165,748,409
Ensembl chr 3:145,281,937...145,288,333
G
Myo1b
myosin Ib
decreases expression
EXP
valdecoxib results in decreased expression of MYO1B mRNA
CTD
PMID:24136188
NCBI chr 9:57,182,059...57,344,335
Ensembl chr 9:49,690,086...49,850,798
G
Naa10
N(alpha)-acetyltransferase 10, NatA catalytic subunit
increases expression
EXP
valdecoxib results in increased expression of NAA10 mRNA
CTD
PMID:24136188
NCBI chr X:156,807,378...156,812,632
Ensembl chr X:151,656,056...151,661,252
G
Nap1l1
nucleosome assembly protein 1-like 1
increases expression
EXP
valdecoxib results in increased expression of NAP1L1 mRNA
CTD
PMID:24136188
NCBI chr 7:46,933,278...46,957,853
Ensembl chr 7:46,933,356...46,956,593
G
Ncald
neurocalcin delta
increases expression
EXP
valdecoxib results in increased expression of NCALD mRNA
CTD
PMID:24136188
NCBI chr 7:68,532,671...68,964,740
Ensembl chr 7:68,534,421...68,964,496
G
Nectin2
nectin cell adhesion molecule 2
decreases expression
EXP
valdecoxib results in decreased expression of NECTIN2 mRNA
CTD
PMID:24136188
NCBI chr 1:88,500,086...88,535,474
Ensembl chr 1:79,372,119...79,407,360
G
Nedd9
neural precursor cell expressed, developmentally down-regulated 9
increases expression
EXP
valdecoxib results in increased expression of NEDD9 mRNA
CTD
PMID:24136188
NCBI chr17:23,495,531...23,673,780
Ensembl chr17:23,282,326...23,468,019
G
Nhp2
NHP2 ribonucleoprotein
increases expression
EXP
valdecoxib results in increased expression of NHP2 mRNA
CTD
PMID:24136188
NCBI chr10:36,378,020...36,381,362
Ensembl chr10:35,877,054...35,882,545
G
Nipsnap1
nipsnap homolog 1
decreases expression
EXP
valdecoxib results in decreased expression of NIPSNAP1 mRNA
CTD
PMID:24136188
NCBI chr14:83,957,714...83,981,579
Ensembl chr14:79,734,209...79,758,098
G
Nmi
N-myc (and STAT) interactor
increases expression
EXP
valdecoxib results in increased expression of NMI mRNA
CTD
PMID:24136188
NCBI chr 3:56,824,778...56,848,891
Ensembl chr 3:36,415,607...36,439,498
G
Nnt
nicotinamide nucleotide transhydrogenase
decreases expression
EXP
valdecoxib results in decreased expression of NNT mRNA
CTD
PMID:24136188
NCBI chr 2:53,144,157...53,237,857
Ensembl chr 2:51,411,413...51,504,823
G
Noct
nocturnin
decreases expression
EXP
valdecoxib results in decreased expression of NOCT mRNA
CTD
PMID:24136188
NCBI chr 2:137,422,074...137,442,282
Ensembl chr 2:135,271,189...135,291,400
G
Nploc4
NPL4 homolog, ubiquitin recognition factor
increases expression
EXP
valdecoxib results in increased expression of NPLOC4 mRNA
CTD
PMID:24136188
NCBI chr10:106,152,756...106,208,306
Ensembl chr10:105,654,812...105,709,913
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
valdecoxib results in increased expression of NQO1 mRNA
CTD
PMID:24136188
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Nr1d2
nuclear receptor subfamily 1, group D, member 2
increases expression
EXP
valdecoxib results in increased expression of NR1D2 mRNA
CTD
PMID:24136188
NCBI chr15:9,955,034...9,981,329
Ensembl chr15:7,524,257...7,550,553
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
decreases expression
EXP
valdecoxib results in decreased expression of NR3C1 mRNA
CTD
PMID:24136188
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Nrbf2
nuclear receptor binding factor 2
decreases expression
EXP
valdecoxib results in decreased expression of NRBF2 mRNA
CTD
PMID:24136188
NCBI chr20:21,307,389...21,325,724
Ensembl chr20:21,308,576...21,326,818
G
Nrep
neuronal regeneration related protein
decreases expression
EXP
valdecoxib results in decreased expression of NREP mRNA
CTD
PMID:24136188
NCBI chr18:25,291,219...25,320,742
Ensembl chr18:25,017,083...25,046,591
G
Nsfl1c
NSFL1 cofactor
increases expression
EXP
valdecoxib results in increased expression of NSFL1C mRNA
CTD
PMID:24136188
NCBI chr 3:160,438,708...160,463,261
Ensembl chr 3:139,978,301...140,002,870
G
Nsmce1
NSE1 homolog, SMC5-SMC6 complex component
increases expression
EXP
valdecoxib results in increased expression of NSMCE1 mRNA
CTD
PMID:24136188
NCBI chr 1:180,030,355...180,058,541
Ensembl chr 1:180,030,160...180,058,417
G
Nt5dc1
5'-nucleotidase domain containing 1
increases expression
EXP
valdecoxib results in increased expression of NT5DC1 mRNA
CTD
PMID:24136188
NCBI chr20:38,105,677...38,208,613
Ensembl chr20:38,105,678...38,208,591
G
Nudc
nuclear distribution C, dynein complex regulator
increases expression
EXP
valdecoxib results in increased expression of NUDC mRNA
CTD
PMID:24136188
NCBI chr 5:151,041,878...151,055,260
Ensembl chr 5:145,758,002...145,771,425
G
Nupr1
nuclear protein 1, transcriptional regulator
decreases expression
EXP
valdecoxib results in decreased expression of NUPR1 mRNA
CTD
PMID:24136188
NCBI chr 1:190,643,866...190,645,901
Ensembl chr 1:181,213,368...181,215,281
G
Nusap1
nucleolar and spindle associated protein 1
decreases expression
EXP
valdecoxib results in decreased expression of NUSAP1 mRNA
CTD
PMID:24136188
NCBI chr 3:127,057,220...127,092,779
Ensembl chr 3:106,603,289...106,633,624
G
Oaf
out at first homolog
decreases expression
EXP
valdecoxib results in decreased expression of OAF mRNA
CTD
PMID:24136188
NCBI chr 8:52,491,314...52,509,285
Ensembl chr 8:43,594,363...43,612,334
G
Oat
ornithine aminotransferase
decreases expression
EXP
valdecoxib results in decreased expression of OAT mRNA
CTD
PMID:24136188
NCBI chr 1:196,777,973...196,797,754
Ensembl chr 1:187,347,865...187,367,682
G
Odc1
ornithine decarboxylase 1
increases expression
EXP
valdecoxib results in increased expression of ODC1 mRNA
CTD
PMID:24136188
NCBI chr 6:46,058,439...46,065,148
Ensembl chr 6:40,329,964...40,336,440
G
Ogn
osteoglycin
decreases expression
EXP
valdecoxib results in decreased expression of OGN mRNA
CTD
PMID:24136188
NCBI chr17:15,238,500...15,259,167
Ensembl chr17:15,032,069...15,052,739
G
Olr59
olfactory receptor 59
decreases expression
EXP
valdecoxib results in decreased expression of OLR59 mRNA
CTD
PMID:24136188
NCBI chr 1:166,604,972...166,639,634
Ensembl chr 1:157,193,080...157,211,179
G
Osbpl11
oxysterol binding protein-like 11
decreases expression
EXP
valdecoxib results in decreased expression of OSBPL11 mRNA
CTD
PMID:24136188
NCBI chr11:81,038,759...81,121,887
Ensembl chr11:67,533,672...67,596,444
G
Osgin1
oxidative stress induced growth inhibitor 1
increases expression
EXP
valdecoxib results in increased expression of OSGIN1 mRNA
CTD
PMID:24136188
NCBI chr19:64,380,336...64,409,165
Ensembl chr19:47,492,171...47,500,516
G
Otc
ornithine transcarbamylase
decreases expression
EXP
valdecoxib results in decreased expression of OTC mRNA
CTD
PMID:24136188
NCBI chr X:15,126,358...15,202,473
Ensembl chr X:12,453,834...12,566,918
G
Otub2
OTU deubiquitinase, ubiquitin aldehyde binding 2
decreases expression
EXP
valdecoxib results in decreased expression of OTUB2 mRNA
CTD
PMID:24136188
NCBI chr 6:128,309,863...128,328,444
Ensembl chr 6:122,545,061...122,563,644
G
P4ha1
prolyl 4-hydroxylase subunit alpha 1
increases expression
EXP
valdecoxib results in increased expression of P4HA1 mRNA
CTD
PMID:24136188
NCBI chr20:27,302,046...27,352,098
Ensembl chr20:27,302,141...27,352,786
G
Paics
phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase
increases expression
EXP
valdecoxib results in increased expression of PAICS mRNA
CTD
PMID:24136188
NCBI chr14:31,553,355...31,586,843
Ensembl chr14:31,173,541...31,232,635
G
Parp1
poly (ADP-ribose) polymerase 1
increases expression
EXP
valdecoxib results in increased expression of PARP1 mRNA
CTD
PMID:24136188
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Parvb
parvin, beta
increases expression
EXP
valdecoxib results in increased expression of PARVB mRNA
CTD
PMID:24136188
NCBI chr 7:117,240,238...117,325,744
Ensembl chr 7:115,360,261...115,445,766
G
Pc
pyruvate carboxylase
decreases expression
EXP
valdecoxib results in decreased expression of PC mRNA
CTD
PMID:24136188
NCBI chr 1:211,228,708...211,327,792
Ensembl chr 1:201,804,267...201,898,380
G
Pcgf6
polycomb group ring finger 6
increases expression
EXP
valdecoxib results in increased expression of PCGF6 mRNA
CTD
PMID:24136188
NCBI chr 1:245,925,354...245,944,964
Ensembl chr 1:245,925,360...245,944,914
G
Pck1
phosphoenolpyruvate carboxykinase 1
decreases expression
EXP
valdecoxib results in decreased expression of PCK1 mRNA
CTD
PMID:24136188
NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:161,930,256...161,936,191
G
Pde4b
phosphodiesterase 4B
decreases expression
EXP
valdecoxib results in decreased expression of PDE4B mRNA
CTD
PMID:24136188
NCBI chr 5:122,028,956...122,598,267
Ensembl chr 5:116,799,971...117,367,696
G
Pdk1
pyruvate dehydrogenase kinase 1
decreases expression
EXP
valdecoxib results in decreased expression of PDK1 mRNA
CTD
PMID:24136188
NCBI chr 3:77,113,464...77,144,145
Ensembl chr 3:56,705,871...56,733,038
G
Pdk2
pyruvate dehydrogenase kinase 2
decreases expression
EXP
valdecoxib results in decreased expression of PDK2 mRNA
CTD
PMID:24136188
NCBI chr10:80,469,388...80,483,988
Ensembl chr10:79,972,556...79,987,085
G
Pdp2
pyruvate dehydrogenase phosphatase catalytic subunit 2
increases expression
EXP
valdecoxib results in increased expression of PDP2 mRNA
CTD
PMID:24136188
NCBI chr19:392,858...400,529
Ensembl chr19:386,406...394,074
G
Pelo
pelota mRNA surveillance and ribosome rescue factor
increases expression
EXP
valdecoxib results in increased expression of PELO mRNA
CTD
PMID:24136188
NCBI chr 2:46,797,853...46,799,621
Ensembl chr 2:46,797,853...46,799,746
G
Per1
period circadian regulator 1
decreases expression
EXP
valdecoxib results in decreased expression of PER1 mRNA
CTD
PMID:24136188
NCBI chr10:54,299,002...54,313,804
Ensembl chr10:53,805,535...53,814,431
G
Per2
period circadian regulator 2
decreases expression
EXP
valdecoxib results in decreased expression of PER2 mRNA
CTD
PMID:24136188
NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:92,007,296...92,049,459
G
Pfdn2
prefoldin subunit 2
increases expression
EXP
valdecoxib results in increased expression of PFDN2 mRNA
CTD
PMID:24136188
NCBI chr13:86,305,037...86,323,008
Ensembl chr13:83,753,877...83,790,504
G
Pfkfb1
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1
decreases expression
EXP
valdecoxib results in decreased expression of PFKFB1 mRNA
CTD
PMID:24136188
NCBI chr X:22,936,038...22,989,691
Ensembl chr X:19,508,546...19,562,182
G
Pgrmc2
progesterone receptor membrane component 2
decreases expression
EXP
valdecoxib results in decreased expression of PGRMC2 mRNA
CTD
PMID:24136188
NCBI chr 2:125,996,190...126,012,090
Ensembl chr 2:124,068,260...124,084,155
G
Phgdh
phosphoglycerate dehydrogenase
increases expression
EXP
valdecoxib results in increased expression of PHGDH mRNA
CTD
PMID:24136188
NCBI chr 2:188,595,700...188,624,789
Ensembl chr 2:185,906,966...185,935,944
G
Phlda2
pleckstrin homology-like domain, family A, member 2
increases expression
EXP
valdecoxib results in increased expression of PHLDA2 mRNA
CTD
PMID:24136188
NCBI chr 1:208,126,302...208,127,241
Ensembl chr 1:198,696,897...198,697,836
G
Phlda3
pleckstrin homology-like domain, family A, member 3
decreases expression
EXP
valdecoxib results in decreased expression of PHLDA3 mRNA
CTD
PMID:24136188
NCBI chr13:49,745,003...49,748,088
Ensembl chr13:47,193,086...47,196,335
G
Phtf1
putative homeodomain transcription factor 1
decreases expression
EXP
valdecoxib results in decreased expression of PHTF1 mRNA
CTD
PMID:24136188
NCBI chr 2:194,161,343...194,249,925
Ensembl chr 2:191,473,130...191,512,078
G
Phyh
phytanoyl-CoA 2-hydroxylase
decreases expression
EXP
valdecoxib results in decreased expression of PHYH mRNA
CTD
PMID:24136188
NCBI chr17:78,238,747...78,255,645
Ensembl chr17:73,329,082...73,346,409
G
Pi4k2b
phosphatidylinositol 4-kinase type 2 beta
increases expression
EXP
valdecoxib results in increased expression of PI4K2B mRNA
CTD
PMID:24136188
NCBI chr14:58,221,790...58,248,716
Ensembl chr14:58,220,437...58,248,673
G
Pigp
phosphatidylinositol glycan anchor biosynthesis, class P
decreases expression
EXP
valdecoxib results in decreased expression of PIGP mRNA
CTD
PMID:24136188
NCBI chr11:47,152,601...47,158,766
Ensembl chr11:33,682,948...33,689,321
G
Pik3c2g
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma
decreases expression
EXP
valdecoxib results in decreased expression of PIK3C2G mRNA
CTD
PMID:24136188
NCBI chr 4:174,215,527...174,583,378
Ensembl chr 4:172,484,345...172,850,544
G
Pir
pirin
increases expression
EXP
valdecoxib results in increased expression of PIR mRNA
CTD
PMID:24136188
NCBI chr X:33,740,428...33,851,049
Ensembl chr X:30,108,538...30,219,218
G
Pisd
phosphatidylserine decarboxylase
increases expression
EXP
valdecoxib results in increased expression of PISD mRNA
CTD
PMID:24136188
NCBI chr14:82,166,401...82,215,479
Ensembl chr14:77,941,948...77,991,003
G
Pkdcc
protein kinase domain containing, cytoplasmic
decreases expression
EXP
valdecoxib results in decreased expression of PKDCC mRNA
CTD
PMID:24136188
NCBI chr 6:17,208,171...17,217,488
Ensembl chr 6:11,455,686...11,465,556
G
Pklr
pyruvate kinase L/R
decreases expression
EXP
valdecoxib results in decreased expression of PKLR mRNA
CTD
PMID:24136188
NCBI chr 2:176,840,779...176,849,637
Ensembl chr 2:174,543,039...174,551,870
G
Pla2g12a
phospholipase A2, group XIIA
increases expression
EXP
valdecoxib results in increased expression of PLA2G12A mRNA
CTD
PMID:24136188
NCBI chr 2:221,110,722...221,126,966
Ensembl chr 2:218,436,513...218,452,740
G
Plaa
phospholipase A2, activating protein
increases expression
EXP
valdecoxib results in increased expression of PLAA mRNA
CTD
PMID:24136188
NCBI chr 5:109,428,600...109,460,373
Ensembl chr 5:109,428,265...109,460,282
G
Pld1
phospholipase D1
decreases expression
EXP
valdecoxib results in decreased expression of PLD1 mRNA
CTD
PMID:24136188
NCBI chr 2:112,777,820...112,975,857
Ensembl chr 2:110,893,608...111,047,692
G
Plekha5
pleckstrin homology domain containing A5
increases expression
EXP
valdecoxib results in increased expression of PLEKHA5 mRNA
CTD
PMID:24136188
NCBI chr 4:173,333,891...173,503,546
Ensembl chr 4:173,334,055...173,503,546
G
Plpp2
phospholipid phosphatase 2
increases expression
EXP
valdecoxib results in increased expression of PLPP2 mRNA
CTD
PMID:24136188
NCBI chr 7:10,175,918...10,184,032
Ensembl chr 7:10,175,948...10,184,071
G
Plpp3
phospholipid phosphatase 3
decreases expression
EXP
valdecoxib results in decreased expression of PLPP3 mRNA
CTD
PMID:24136188
NCBI chr 5:125,156,000...125,231,119
Ensembl chr 5:119,927,085...120,002,205
G
Pls3
plastin 3
increases expression
EXP
valdecoxib results in increased expression of PLS3 mRNA
CTD
PMID:24136188
NCBI chr X:116,401,247...116,495,898
Ensembl chr X:111,589,254...111,683,891
G
Plxna2
plexin A2
decreases expression
EXP
valdecoxib results in decreased expression of PLXNA2 mRNA
CTD
PMID:24136188
NCBI chr13:106,163,103...106,358,979
Ensembl chr13:106,163,103...106,358,979
G
Pmm1
phosphomannomutase 1
increases expression
EXP
valdecoxib results in increased expression of PMM1 mRNA
CTD
PMID:24136188
NCBI chr 7:115,346,767...115,357,137
Ensembl chr 7:113,466,632...113,477,022
G
Pno1
partner of NOB1 homolog
increases expression
EXP
valdecoxib results in increased expression of PNO1 mRNA
CTD
PMID:24136188
NCBI chr14:95,811,335...95,819,903
Ensembl chr14:91,609,233...91,618,324
G
Pnpla3
patatin-like phospholipase domain containing 3
decreases expression
EXP
valdecoxib results in decreased expression of PNPLA3 mRNA
CTD
PMID:24136188
NCBI chr 7:117,173,485...117,194,065
Ensembl chr 7:115,293,538...115,314,077
G
Pnpla7
patatin-like phospholipase domain containing 7
increases expression
EXP
valdecoxib results in increased expression of PNPLA7 mRNA
CTD
PMID:24136188
NCBI chr 3:7,782,572...7,861,504
Ensembl chr 3:7,782,572...7,861,497
G
Polr3g
RNA polymerase III subunit G
increases expression
EXP
valdecoxib results in increased expression of POLR3G mRNA
CTD
PMID:24136188
NCBI chr 2:13,680,893...13,721,802
Ensembl chr 2:11,945,217...11,986,125
G
Por
cytochrome p450 oxidoreductase
increases expression
EXP
valdecoxib results in increased expression of POR mRNA
CTD
PMID:24136188
NCBI chr12:26,587,674...26,655,612
Ensembl chr12:20,951,058...20,999,245
G
Ppid
peptidylprolyl isomerase D
increases expression
EXP
valdecoxib results in increased expression of PPID mRNA
CTD
PMID:24136188
NCBI chr 2:167,025,985...167,037,998
Ensembl chr 2:164,727,779...164,740,221
G
Ppp1r14b
protein phosphatase 1, regulatory (inhibitor) subunit 14B
increases expression
EXP
valdecoxib results in increased expression of PPP1R14B mRNA
CTD
PMID:24136188
NCBI chr 1:213,594,416...213,596,527
Ensembl chr 1:204,163,299...204,167,319 Ensembl chr12:204,163,299...204,167,319
G
Ppp1r3b
protein phosphatase 1, regulatory subunit 3B
decreases expression
EXP
valdecoxib results in decreased expression of PPP1R3B mRNA
CTD
PMID:24136188
NCBI chr16:63,533,318...63,545,683
Ensembl chr16:56,829,660...56,842,406
G
Ppp2r1b
protein phosphatase 2 scaffold subunit A beta
increases expression
EXP
valdecoxib results in increased expression of PPP2R1B mRNA
CTD
PMID:24136188
NCBI chr 8:51,195,860...51,228,442
Ensembl chr 8:51,186,717...51,228,485
G
Ppp2r5e
protein phosphatase 2 regulatory subunit B', epsilon
decreases expression
EXP
valdecoxib results in decreased expression of PPP2R5E mRNA
CTD
PMID:24136188
NCBI chr 6:99,904,569...100,053,672
Ensembl chr 6:94,168,846...94,317,872
G
Prcp
prolylcarboxypeptidase
decreases expression
EXP
valdecoxib results in decreased expression of PRCP mRNA
CTD
PMID:24136188
NCBI chr 1:156,343,894...156,396,295
Ensembl chr 1:146,930,561...146,984,530
G
Prodh
proline dehydrogenase
decreases expression
EXP
valdecoxib results in decreased expression of PRODH mRNA
CTD
PMID:24136188
NCBI chr11:82,910,043...82,927,305
Ensembl chr11:82,910,137...82,927,305
G
Prpf19
pre-mRNA processing factor 19
increases expression
EXP
valdecoxib results in increased expression of PRPF19 mRNA
CTD
PMID:24136188
NCBI chr 1:216,966,104...216,977,549
Ensembl chr 1:207,541,595...207,552,662
G
Prps1
phosphoribosyl pyrophosphate synthetase 1
increases expression
EXP
valdecoxib results in increased expression of PRPS1 mRNA
CTD
PMID:24136188
NCBI chr X:108,920,663...108,942,713
Ensembl chr X:104,132,141...104,154,187
G
Psip1
PC4 and SRSF1 interacting protein 1
increases expression
EXP
valdecoxib results in increased expression of PSIP1 mRNA
CTD
PMID:24136188
NCBI chr 5:102,892,929...102,925,191
Ensembl chr 5:97,847,015...97,879,257
G
Psma1
proteasome 20S subunit alpha 1
increases expression
EXP
valdecoxib results in increased expression of PSMA1 mRNA
CTD
PMID:24136188
NCBI chr 1:177,876,838...177,887,857
Ensembl chr 1:168,440,936...168,453,472
G
Psma2
proteasome 20S subunit alpha 2
increases expression
EXP
valdecoxib results in increased expression of PSMA2 mRNA
CTD
PMID:24136188
NCBI chr17:50,554,536...50,564,923
Ensembl chr17:50,551,924...50,564,938
G
Psma3
proteasome 20S subunit alpha 3
increases expression
EXP
valdecoxib results in increased expression of PSMA3 mRNA
CTD
PMID:24136188
NCBI chr 6:95,219,714...95,239,745
Ensembl chr 6:89,483,727...89,504,965
G
Psma4
proteasome 20S subunit alpha 4
increases expression
EXP
valdecoxib results in increased expression of PSMA4 mRNA
CTD
PMID:24136188
NCBI chr 8:64,236,520...64,243,980
Ensembl chr 8:55,340,386...55,347,890
G
Psma5
proteasome 20S subunit alpha 5
increases expression
EXP
valdecoxib results in increased expression of PSMA5 mRNA
CTD
PMID:24136188
NCBI chr 2:195,896,369...195,919,733
Ensembl chr 2:195,896,365...195,919,731
G
Psma6
proteasome 20S subunit alpha 6
increases expression
EXP
valdecoxib results in increased expression of PSMA6 mRNA
CTD
PMID:24136188
NCBI chr 6:78,500,676...78,531,693
Ensembl chr 6:72,765,473...72,796,554
G
Psma7
proteasome 20S subunit alpha 7
increases expression
EXP
valdecoxib results in increased expression of PSMA7 mRNA
CTD
PMID:24136188
NCBI chr 3:167,137,279...167,143,626
Ensembl chr 3:167,137,263...167,143,672
G
Psmb1
proteasome 20S subunit beta 1
increases expression
EXP
valdecoxib results in increased expression of PSMB1 mRNA
CTD
PMID:24136188
NCBI chr 1:65,115,770...65,136,516
Ensembl chr 1:56,420,618...56,463,560
G
Psmb10
proteasome 20S subunit beta 10
increases expression
EXP
valdecoxib results in increased expression of PSMB10 mRNA
CTD
PMID:24136188
NCBI chr19:50,740,808...50,743,292
Ensembl chr19:33,827,229...33,833,626
G
Psmb2
proteasome 20S subunit beta 2
increases expression
EXP
valdecoxib results in increased expression of PSMB2 mRNA
CTD
PMID:24136188
NCBI chr 5:144,255,058...144,287,200
Ensembl chr 5:138,970,533...139,021,137
G
Psmb3
proteasome 20S subunit beta 3
increases expression
EXP
valdecoxib results in increased expression of PSMB3 mRNA
CTD
PMID:24136188
NCBI chr10:82,697,425...82,704,521
Ensembl chr10:82,697,425...82,704,521
G
Psmb4
proteasome 20S subunit beta 4
increases expression
EXP
valdecoxib results in increased expression of PSMB4 mRNA
CTD
PMID:24136188
NCBI chr 2:185,131,787...185,134,561
Ensembl chr 2:182,442,756...182,445,746
G
Psmb5
proteasome 20S subunit beta 5
increases expression
EXP
valdecoxib results in increased expression of PSMB5 mRNA
CTD
PMID:24136188
NCBI chr15:32,042,784...32,047,379
Ensembl chr15:28,072,781...28,077,440
G
Psmb6
proteasome 20S subunit beta 6
increases expression
EXP
valdecoxib results in increased expression of PSMB6 mRNA
CTD
PMID:24136188
NCBI chr10:55,737,852...55,740,218
Ensembl chr10:55,239,241...55,241,586
G
Psmb7
proteasome 20S subunit beta 7
increases expression
EXP
valdecoxib results in increased expression of PSMB7 mRNA
CTD
PMID:24136188
NCBI chr 3:42,767,500...42,827,470
Ensembl chr 3:22,354,698...22,417,937
G
Psmc1
proteasome 26S subunit, ATPase 1
increases expression
EXP
valdecoxib results in increased expression of PSMC1 mRNA
CTD
PMID:24136188
NCBI chr 6:125,122,497...125,134,859
Ensembl chr 6:119,392,855...119,410,123
G
Psmc2
proteasome 26S subunit, ATPase 2
increases expression
EXP
valdecoxib results in increased expression of PSMC2 mRNA
CTD
PMID:24136188
NCBI chr 4:13,255,850...13,270,160
Ensembl chr 4:13,255,856...13,270,185
G
Psmc3
proteasome 26S subunit, ATPase 3
increases expression
EXP
valdecoxib results in increased expression of PSMC3 mRNA
CTD
PMID:24136188
NCBI chr 3:77,031,825...77,037,207
Ensembl chr 3:77,031,825...77,043,358
G
Psmc4
proteasome 26S subunit, ATPase 4
increases expression
EXP
valdecoxib results in increased expression of PSMC4 mRNA
CTD
PMID:24136188
NCBI chr 1:92,476,690...92,485,268
Ensembl chr 1:83,348,592...83,357,494
G
Psmc5
proteasome 26S subunit, ATPase 5
increases expression
EXP
valdecoxib results in increased expression of PSMC5 mRNA
CTD
PMID:24136188
NCBI chr10:91,687,553...91,693,487
Ensembl chr10:91,187,743...91,213,135
G
Psmc6
proteasome 26S subunit, ATPase 6
increases expression
EXP
valdecoxib results in increased expression of PSMC6 mRNA
CTD
PMID:24136188
NCBI chr15:21,022,314...21,043,785
Ensembl chr15:18,542,563...18,564,055
G
Psmd1
proteasome 26S subunit, non-ATPase 1
increases expression
EXP
valdecoxib results in increased expression of PSMD1 mRNA
CTD
PMID:24136188
NCBI chr 9:86,709,714...86,785,213
Ensembl chr 9:86,709,947...86,785,211
G
Psmd11
proteasome 26S subunit, non-ATPase 11
increases expression
EXP
valdecoxib results in increased expression of PSMD11 mRNA
CTD
PMID:24136188
NCBI chr10:65,433,853...65,479,774
Ensembl chr10:65,433,853...65,479,766
G
Psmd12
proteasome 26S subunit, non-ATPase 12
increases expression
EXP
valdecoxib results in increased expression of PSMD12 mRNA
CTD
PMID:24136188
NCBI chr10:92,937,957...92,956,601
Ensembl chr10:92,438,298...92,457,287
G
Psmd13
proteasome 26S subunit, non-ATPase 13
increases expression
EXP
valdecoxib results in increased expression of PSMD13 mRNA
CTD
PMID:24136188
NCBI chr 1:205,394,248...205,406,525
Ensembl chr 1:195,964,138...195,976,905
G
Psmd14
proteasome 26S subunit, non-ATPase 14
increases expression
EXP
valdecoxib results in increased expression of PSMD14 mRNA
CTD
PMID:24136188
NCBI chr 3:66,662,933...66,755,666
Ensembl chr 3:46,254,330...46,347,076
G
Psmd2
proteasome 26S subunit ubiquitin receptor, non-ATPase 2
increases expression
EXP
valdecoxib results in increased expression of PSMD2 mRNA
CTD
PMID:24136188
NCBI chr11:93,752,761...93,763,388
Ensembl chr11:80,248,364...80,259,043
G
Psmd3
proteasome 26S subunit, non-ATPase 3
increases expression
EXP
valdecoxib results in increased expression of PSMD3 mRNA
CTD
PMID:24136188
NCBI chr10:83,643,473...83,655,620
Ensembl chr10:83,643,647...83,655,618
G
Psmd4
proteasome 26S subunit ubiquitin receptor, non-ATPase 4
increases expression
EXP
valdecoxib results in increased expression of PSMD4 mRNA
CTD
PMID:24136188
NCBI chr 2:185,287,941...185,297,238
Ensembl chr 2:182,598,934...182,608,194
G
Psmd5
proteasome 26S subunit, non-ATPase 5
increases expression
EXP
valdecoxib results in increased expression of PSMD5 mRNA
CTD
PMID:24136188
NCBI chr 3:18,133,715...18,151,000
Ensembl chr 3:18,133,717...18,151,029
G
Psmd6
proteasome 26S subunit, non-ATPase 6
increases expression
EXP
valdecoxib results in increased expression of PSMD6 mRNA
CTD
PMID:24136188
NCBI chr15:13,532,675...13,542,682
Ensembl chr15:11,102,180...11,205,620
G
Psmd7
proteasome 26S subunit, non-ATPase 7
increases expression
EXP
valdecoxib results in increased expression of PSMD7 mRNA
CTD
PMID:24136188
NCBI chr19:52,404,032...52,411,316
Ensembl chr19:35,494,316...35,501,588
G
Psmd8
proteasome 26S subunit, non-ATPase 8
increases expression
EXP
valdecoxib results in increased expression of PSMD8 mRNA
CTD
PMID:24136188
NCBI chr 1:84,474,377...84,481,209
Ensembl chr 1:84,474,378...84,481,209
G
Psme4
proteasome activator subunit 4
increases expression
EXP
valdecoxib results in increased expression of PSME4 mRNA
CTD
PMID:24136188
NCBI chr14:104,505,716...104,609,410
Ensembl chr14:104,505,716...104,609,408
G
Ptdss2
phosphatidylserine synthase 2
increases expression
EXP
valdecoxib results in increased expression of PTDSS2 mRNA
CTD
PMID:24136188
NCBI chr 1:196,241,439...196,267,632
Ensembl chr 1:196,241,494...196,267,685
G
Ptges3
prostaglandin E synthase 3
increases expression
EXP
valdecoxib results in increased expression of PTGES3 mRNA
CTD
PMID:24136188
NCBI chr 7:1,075,230...1,092,363
Ensembl chr 7:490,656...508,084
G
Ptgis
prostaglandin I2 synthase
decreases expression
EXP
valdecoxib results in decreased expression of PTGIS mRNA
CTD
PMID:24136188
NCBI chr 3:176,347,589...176,383,251
Ensembl chr 3:155,916,412...155,965,451
G
Ptgr1
prostaglandin reductase 1
decreases expression
EXP
valdecoxib results in decreased expression of PTGR1 mRNA
CTD
PMID:24136188
NCBI chr 5:78,579,060...78,597,671
Ensembl chr 5:73,784,009...73,802,666
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases activity
ISO
valdecoxib results in decreased activity of PTGS2 protein
CTD
PMID:15887009 PMID:17164136
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Ptpn21
protein tyrosine phosphatase, non-receptor type 21
increases expression
EXP
valdecoxib results in increased expression of PTPN21 mRNA
CTD
PMID:24136188
NCBI chr 6:117,933,066...117,998,095
Ensembl chr 6:117,933,066...117,998,095
G
Ptprd
protein tyrosine phosphatase, receptor type, D
decreases expression
EXP
valdecoxib results in decreased expression of PTPRD mRNA
CTD
PMID:24136188
NCBI chr 5:95,093,221...97,415,498
Ensembl chr 5:90,048,966...92,369,396
G
Ptprn
protein tyrosine phosphatase, receptor type, N
decreases expression
EXP
valdecoxib results in decreased expression of PTPRN mRNA
CTD
PMID:24136188
NCBI chr 9:76,741,010...76,756,704
Ensembl chr 9:76,741,016...76,756,190
G
Pttg1
PTTG1 regulator of sister chromatid separation, securin
decreases expression
EXP
valdecoxib results in decreased expression of PTTG1 mRNA
CTD
PMID:24136188
NCBI chr10:28,394,940...28,406,410
Ensembl chr10:27,893,689...27,904,837
G
Pygl
glycogen phosphorylase L
decreases expression
EXP
valdecoxib results in decreased expression of PYGL mRNA
CTD
PMID:24136188
NCBI chr 6:94,433,558...94,476,219
Ensembl chr 6:88,697,593...88,740,310
G
Pyroxd2
pyridine nucleotide-disulphide oxidoreductase domain 2
decreases expression
EXP
valdecoxib results in decreased expression of PYROXD2 mRNA
CTD
PMID:24136188
NCBI chr 1:251,472,609...251,498,316
Ensembl chr 1:241,523,377...241,548,761
G
Qprt
quinolinate phosphoribosyltransferase
decreases expression
EXP
valdecoxib results in decreased expression of QPRT mRNA
CTD
PMID:24136188
NCBI chr 1:181,718,189...181,733,486
Ensembl chr 1:181,718,190...181,733,486
G
R3hdm2
R3H domain containing 2
decreases expression
EXP
valdecoxib results in decreased expression of R3HDM2 mRNA
CTD
PMID:24136188
NCBI chr 7:65,097,685...65,225,863
Ensembl chr 7:63,232,346...63,340,540
G
Rab30
RAB30, member RAS oncogene family
increases expression
EXP
valdecoxib results in increased expression of RAB30 mRNA
CTD
PMID:24136188
NCBI chr 1:156,216,137...156,310,778
Ensembl chr 1:146,803,714...146,892,181
G
Rab40b
Rab40b, member RAS oncogene family
decreases expression
EXP
valdecoxib results in decreased expression of RAB40B mRNA
CTD
PMID:24136188
NCBI chr10:106,631,514...106,659,090
Ensembl chr10:106,631,514...106,659,090
G
Rab5if
RAB5 interacting factor
increases expression
EXP
valdecoxib results in increased expression of RAB5IF mRNA
CTD
PMID:24136188
NCBI chr 3:145,357,990...145,368,012
Ensembl chr 3:145,357,861...145,368,012
G
Rad23b
RAD23 homolog B, nucleotide excision repair protein
increases expression
EXP
valdecoxib results in increased expression of RAD23B mRNA
CTD
PMID:24136188
NCBI chr 5:74,885,518...74,923,621
Ensembl chr 5:70,090,232...70,128,319
G
Ran
RAN, member RAS oncogene family
increases expression
EXP
valdecoxib results in increased expression of RAN mRNA
CTD
PMID:24136188
NCBI chr12:33,311,155...33,314,339
Ensembl chr12:27,674,050...27,678,276
G
Rangrf
RAN guanine nucleotide release factor
increases expression
EXP
valdecoxib results in increased expression of RANGRF mRNA
CTD
PMID:24136188
NCBI chr10:54,176,325...54,177,696
Ensembl chr10:53,677,467...53,678,840
G
Rapgef4
Rap guanine nucleotide exchange factor 4
increases expression
EXP
valdecoxib results in increased expression of RAPGEF4 mRNA
CTD
PMID:24136188
NCBI chr 3:77,217,024...77,509,933
Ensembl chr 3:56,809,270...57,102,316
G
Raph1
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1
increases expression
EXP
valdecoxib results in increased expression of RAPH1 mRNA
CTD
PMID:24136188
NCBI chr 9:69,397,272...69,484,174
Ensembl chr 9:61,907,758...61,961,209
G
Rarb
retinoic acid receptor, beta
decreases expression
EXP
valdecoxib results in decreased expression of RARB mRNA
CTD
PMID:24136188
NCBI chr15:10,837,252...11,482,037
Ensembl chr15:8,406,492...9,051,288
G
Rb1
RB transcriptional corepressor 1
decreases expression
EXP
valdecoxib results in decreased expression of RB1 mRNA
CTD
PMID:24136188
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:48,371,296...48,502,302
G
Rb1cc1
RB1-inducible coiled-coil 1
increases expression
EXP
valdecoxib results in increased expression of RB1CC1 mRNA
CTD
PMID:24136188
NCBI chr 5:17,948,522...18,012,434
Ensembl chr 5:13,161,648...13,225,560
G
Rbbp6
RB binding protein 6, ubiquitin ligase
increases expression
EXP
valdecoxib results in increased expression of RBBP6 mRNA
CTD
PMID:24136188
NCBI chr 1:186,934,563...186,966,852
Ensembl chr 1:177,503,313...177,535,678
G
Rbbp8
RB binding protein 8, endonuclease
increases expression
EXP
valdecoxib results in increased expression of RBBP8 mRNA
CTD
PMID:24136188
NCBI chr18:3,198,188...3,263,643
Ensembl chr18:2,921,286...2,988,846
G
Rbis
ribosomal biogenesis factor
increases expression
EXP
valdecoxib results in increased expression of RBIS mRNA
CTD
PMID:24136188
NCBI chr 2:88,702,599...88,718,587
Ensembl chr 2:86,991,315...87,041,339
G
Rbm5
RNA binding motif protein 5
increases expression
EXP
valdecoxib results in increased expression of RBM5 mRNA
CTD
PMID:24136188
NCBI chr 8:117,298,866...117,328,107
Ensembl chr 8:108,420,222...108,449,430
G
Rbp1
retinol binding protein 1
decreases expression
EXP
valdecoxib results in decreased expression of RBP1 mRNA
CTD
PMID:24136188
NCBI chr 8:107,904,589...107,926,109
Ensembl chr 8:99,025,206...99,046,743
G
Rbpms
RNA binding protein, mRNA processing factor
increases expression
EXP
valdecoxib results in increased expression of RBPMS mRNA
CTD
PMID:24136188
NCBI chr16:64,942,159...65,098,504
Ensembl chr16:58,239,474...58,395,426
G
Rbx1
ring-box 1
increases expression
EXP
valdecoxib results in increased expression of RBX1 mRNA
CTD
PMID:24136188
NCBI chr 7:114,870,893...114,881,194
Ensembl chr 7:112,990,835...113,001,051
G
Rcan1
regulator of calcineurin 1
decreases expression
EXP
valdecoxib results in decreased expression of RCAN1 mRNA
CTD
PMID:24136188
NCBI chr11:45,108,123...45,188,065
Ensembl chr11:31,622,210...31,702,045
G
Rdh5
retinol dehydrogenase 5
decreases expression
EXP
valdecoxib results in decreased expression of RDH5 mRNA
CTD
PMID:24136188
NCBI chr 7:1,912,120...1,931,836
Ensembl chr 7:1,340,934...1,351,558
G
Rell1
RELT-like 1
increases expression
EXP
valdecoxib results in increased expression of RELL1 mRNA
CTD
PMID:24136188
NCBI chr14:44,318,640...44,378,541
Ensembl chr14:44,303,009...44,378,500
G
Rex1bd
required for excision 1-B domain containing
increases expression
EXP
valdecoxib results in increased expression of REX1BD mRNA
CTD
PMID:24136188
NCBI chr16:18,922,050...18,924,521
Ensembl chr16:18,922,037...18,924,526
G
Rexo2
RNA exonuclease 2
increases expression
EXP
valdecoxib results in increased expression of REXO2 mRNA
CTD
PMID:24136188
NCBI chr 8:57,708,420...57,720,142
Ensembl chr 8:48,811,900...48,823,622
G
Rfc2
replication factor C subunit 2
increases expression
EXP
valdecoxib results in increased expression of RFC2 mRNA
CTD
PMID:24136188
NCBI chr12:27,756,920...27,770,049
Ensembl chr12:22,120,010...22,133,557
G
Rgn
regucalcin
decreases expression
EXP
valdecoxib results in decreased expression of RGN mRNA
CTD
PMID:24136188
NCBI chr X:4,172,537...4,190,112
Ensembl chr X:1,619,032...1,634,450
G
Rhpn2
rhophilin, Rho GTPase binding protein 2
increases expression
EXP
valdecoxib results in increased expression of RHPN2 mRNA
CTD
PMID:24136188
NCBI chr 1:97,128,054...97,188,803
Ensembl chr 1:87,991,144...88,051,902
G
Rmdn2
regulator of microtubule dynamics 2
decreases expression
EXP
valdecoxib results in decreased expression of RMDN2 mRNA
CTD
PMID:24136188
NCBI chr 6:15,372,569...15,443,000
Ensembl chr 6:15,375,496...15,441,480
G
Rnase4
ribonuclease A family member 4
decreases expression
EXP
valdecoxib results in decreased expression of RNASE4 mRNA
CTD
PMID:24136188
NCBI chr15:26,786,287...26,803,634
Ensembl chr15:24,312,464...24,330,117
G
Rorc
RAR-related orphan receptor C
decreases expression
EXP
valdecoxib results in decreased expression of RORC mRNA
CTD
PMID:24136188
NCBI chr 2:184,698,779...184,723,942
Ensembl chr 2:182,009,286...182,034,907
G
Rpa1
replication protein A1
decreases expression
EXP
valdecoxib results in decreased expression of RPA1 mRNA
CTD
PMID:24136188
NCBI chr10:60,647,185...60,698,279
Ensembl chr10:60,148,793...60,199,949
G
Rprm
reprimo, TP53 dependent G2 arrest mediator homolog
decreases expression
EXP
valdecoxib results in decreased expression of RPRM mRNA
CTD
PMID:24136188
NCBI chr 3:58,948,618...58,950,035
Ensembl chr 3:38,539,581...38,540,998
G
Rrm2
ribonucleotide reductase regulatory subunit M2
decreases expression
EXP
valdecoxib results in decreased expression of RRM2 mRNA
CTD
PMID:24136188
NCBI chr 6:47,044,755...47,075,370
Ensembl chr 6:41,340,557...41,346,773
G
RT1-DMa
RT1 class II, locus DMa
affects expression
ISO
valdecoxib affects the expression of HLA-DMA mRNA
CTD
PMID:25811541
NCBI chr20:4,708,932...4,712,335
Ensembl chr20:4,707,028...4,710,432
G
RT1-DMb
RT1 class II, locus DMb
affects expression
ISO
valdecoxib affects the expression of HLA-DMB mRNA
CTD
PMID:25811541
NCBI chr20:4,695,009...4,702,560
Ensembl chr20:4,693,103...4,700,340
G
RT1-Ha
RT1 class II, locus Ha
affects expression
ISO
valdecoxib affects the expression of HLA-DPA1 mRNA
CTD
PMID:25811541
NCBI chr20:4,762,425...4,772,439
Ensembl chr20:4,760,118...4,770,244
G
S1pr1
sphingosine-1-phosphate receptor 1
decreases expression
EXP
valdecoxib results in decreased expression of S1PR1 mRNA
CTD
PMID:24136188
NCBI chr 2:206,309,715...206,314,070
Ensembl chr 2:203,621,587...203,629,681
G
Samd11
sterile alpha motif domain containing 11
decreases expression
EXP
valdecoxib results in decreased expression of SAMD11 mRNA
CTD
PMID:24136188
NCBI chr 5:172,113,900...172,142,026
Ensembl chr 5:166,831,663...166,850,009
G
Sardh
sarcosine dehydrogenase
decreases expression
EXP
valdecoxib results in decreased expression of SARDH mRNA
CTD
PMID:24136188
NCBI chr 3:30,908,621...30,973,409
Ensembl chr 3:10,510,553...10,573,874
G
Sbno1
strawberry notch homolog 1
increases expression
EXP
valdecoxib results in increased expression of SBNO1 mRNA
CTD
PMID:24136188
NCBI chr12:37,835,306...37,895,861
Ensembl chr12:32,185,485...32,230,158
G
Sbno2
strawberry notch homolog 2
increases expression
EXP
valdecoxib results in increased expression of SBNO2 mRNA
CTD
PMID:24136188
NCBI chr 7:10,256,221...10,300,175
Ensembl chr 7:9,605,627...9,649,527
G
Sc5d
sterol-C5-desaturase
increases expression
EXP
valdecoxib results in increased expression of SC5D mRNA
CTD
PMID:24136188
NCBI chr 8:51,526,669...51,538,277
Ensembl chr 8:42,632,672...42,641,273
G
Scarb2
scavenger receptor class B, member 2
increases expression
EXP
valdecoxib results in increased expression of SCARB2 mRNA
CTD
PMID:24136188
NCBI chr14:15,842,583...15,894,123
Ensembl chr14:15,558,236...15,609,813
G
Scd
stearoyl-CoA desaturase
decreases expression
EXP
valdecoxib results in decreased expression of SCD1 mRNA
CTD
PMID:24136188
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:243,269,747...243,282,562
G
Scn1b
sodium voltage-gated channel beta subunit 1
increases expression
EXP
valdecoxib results in increased expression of SCN1B mRNA
CTD
PMID:24136188
NCBI chr 1:95,481,298...95,491,211
Ensembl chr 1:86,353,917...86,363,739
G
Sds
serine dehydratase
decreases expression
EXP
valdecoxib results in decreased expression of SDS mRNA
CTD
PMID:24136188
NCBI chr12:41,743,796...41,751,108
Ensembl chr12:36,083,229...36,088,203
G
Sdsl
serine dehydratase-like
decreases expression
EXP
valdecoxib results in decreased expression of SDSL mRNA
CTD
PMID:24136188
NCBI chr12:41,760,252...41,770,465
Ensembl chr12:36,099,693...36,109,906
G
Sephs1
selenophosphate synthetase 1
increases expression
EXP
valdecoxib results in increased expression of SEPHS1 mRNA
CTD
PMID:24136188
NCBI chr17:73,354,435...73,382,803
Ensembl chr17:73,356,530...73,382,593
G
Serpinf1
serpin family F member 1
decreases expression
EXP
valdecoxib results in decreased expression of SERPINF1 mRNA
CTD
PMID:24136188
NCBI chr10:60,748,504...60,760,898
Ensembl chr10:60,249,708...60,262,646
G
Sertad3
SERTA domain containing 3
increases expression
EXP
valdecoxib results in increased expression of SERTAD3 mRNA
CTD
PMID:24136188
NCBI chr 1:82,763,535...82,767,271
Ensembl chr 1:82,763,149...82,769,001
G
Sesn1
sestrin 1
decreases expression
EXP
valdecoxib results in decreased expression of SESN1 mRNA
CTD
PMID:24136188
NCBI chr20:46,876,918...46,970,010
Ensembl chr20:45,294,871...45,387,697
G
Sesn2
sestrin 2
decreases expression
EXP
valdecoxib results in decreased expression of SESN2 mRNA
CTD
PMID:24136188
NCBI chr 5:149,986,304...150,005,255
Ensembl chr 5:144,701,530...144,721,260
G
Setd4
SET domain containing 4
increases expression
EXP
valdecoxib results in increased expression of SETD4 mRNA
CTD
PMID:24136188
NCBI chr11:46,315,340...46,344,024
Ensembl chr11:32,838,063...32,858,243
G
Sez6
seizure related 6 homolog
decreases expression
EXP
valdecoxib results in decreased expression of SEZ6 mRNA
CTD
PMID:24136188
NCBI chr10:63,317,065...63,366,733
Ensembl chr10:62,819,069...62,868,671
G
Sfmbt1
Scm-like with four mbt domains 1
increases expression
EXP
valdecoxib results in increased expression of SFMBT1 mRNA
CTD
PMID:24136188
NCBI chr16:5,896,686...6,016,311
Ensembl chr16:5,890,782...6,006,605
G
Sgf29
SAGA complex associated factor 29
increases expression
EXP
valdecoxib results in increased expression of SGF29 mRNA
CTD
PMID:24136188
NCBI chr 1:190,668,803...190,702,500
Ensembl chr 1:181,238,468...181,274,781
G
Sgpl1
sphingosine-1-phosphate lyase 1
increases expression
EXP
valdecoxib results in increased expression of SGPL1 mRNA
CTD
PMID:24136188
NCBI chr20:29,590,652...29,637,064
Ensembl chr20:29,047,796...29,094,084
G
Shc1
SHC adaptor protein 1
increases expression
EXP
valdecoxib results in increased expression of SHC1 mRNA
CTD
PMID:24136188
NCBI chr 2:177,135,649...177,147,257
Ensembl chr 2:174,837,930...174,849,536
G
Sik2
salt-inducible kinase 2
increases expression
EXP
valdecoxib results in increased expression of SIK2 mRNA
CTD
PMID:24136188
NCBI chr 8:51,225,543...51,325,343
Ensembl chr 8:51,225,543...51,325,415
G
Sirt3
sirtuin 3
decreases expression
EXP
valdecoxib results in decreased expression of SIRT3 mRNA
CTD
PMID:24136188
NCBI chr 1:205,371,703...205,394,145
Ensembl chr 1:195,942,073...195,964,808
G
Sirt5
sirtuin 5
decreases expression
EXP
valdecoxib results in decreased expression of SIRT5 mRNA
CTD
PMID:24136188
NCBI chr17:21,515,982...21,543,529
Ensembl chr17:21,310,028...21,337,101
G
Slc16a7
solute carrier family 16 member 7
increases expression
EXP
valdecoxib results in increased expression of SLC16A7 mRNA
CTD
PMID:24136188
NCBI chr 7:62,929,067...63,096,995
Ensembl chr 7:61,051,167...61,154,994
G
Slc17a3
solute carrier family 17 member 3
increases expression
EXP
valdecoxib results in increased expression of SLC17A3 mRNA
CTD
PMID:24136188
NCBI chr17:41,270,804...41,300,132
Ensembl chr17:41,270,812...41,295,256
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
valdecoxib inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:48,121,061...48,163,268
G
Slc22a5
solute carrier family 22 member 5
increases expression
EXP
valdecoxib results in increased expression of SLC22A5 mRNA
CTD
PMID:24136188
NCBI chr10:38,509,072...38,536,240
Ensembl chr10:38,008,311...38,035,309
G
Slc22a8
solute carrier family 22 member 8
decreases expression
EXP
valdecoxib results in decreased expression of SLC22A8 mRNA
CTD
PMID:24136188
NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:205,498,084...205,517,450
G
Slc25a12
solute carrier family 25 member 12
increases expression
EXP
valdecoxib results in increased expression of SLC25A12 mRNA
CTD
PMID:24136188
NCBI chr 3:76,504,868...76,599,536
Ensembl chr 3:56,097,269...56,192,100
G
Slc25a15
solute carrier family 25 member 15
decreases expression
EXP
valdecoxib results in decreased expression of SLC25A15 mRNA
CTD
PMID:24136188
NCBI chr16:76,334,037...76,357,325
Ensembl chr16:69,634,414...69,653,010
G
Slc25a23
solute carrier family 25 member 23
decreases expression
EXP
valdecoxib results in decreased expression of SLC25A23 mRNA
CTD
PMID:24136188
NCBI chr 9:1,969,633...1,985,365
Ensembl chr 9:1,882,621...1,898,561
G
Slc25a25
solute carrier family 25 member 25
decreases expression
EXP
valdecoxib results in decreased expression of SLC25A25 mRNA
CTD
PMID:24136188
NCBI chr 3:36,106,448...36,139,812
Ensembl chr 3:15,708,703...15,742,216
G
Slc25a37
solute carrier family 25 member 37
increases expression
EXP
valdecoxib results in increased expression of SLC25A37 mRNA
CTD
PMID:24136188
NCBI chr15:50,944,085...50,986,506
Ensembl chr15:44,536,727...44,577,199
G
Slc2a2
solute carrier family 2 member 2
decreases expression
EXP
valdecoxib results in decreased expression of SLC2A2 mRNA
CTD
PMID:24136188
NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:111,611,774...111,639,933
G
Slc2a5
solute carrier family 2 member 5
decreases expression
EXP
valdecoxib results in decreased expression of SLC2A5 mRNA
CTD
PMID:24136188
NCBI chr 5:165,857,412...165,892,928
Ensembl chr 5:160,583,234...160,611,106
G
Slc31a1
solute carrier family 31 member 1
decreases expression
EXP
valdecoxib results in decreased expression of SLC31A1 mRNA
CTD
PMID:24136188
NCBI chr 5:80,830,574...80,859,810
Ensembl chr 5:75,814,743...75,844,228
G
Slc34a2
solute carrier family 34 member 2
decreases expression
EXP
valdecoxib results in decreased expression of SLC34A2 mRNA
CTD
PMID:24136188
NCBI chr14:62,123,313...62,153,020
Ensembl chr14:57,910,480...57,930,436
G
Slc35e3
solute carrier family 35, member E3
increases expression
EXP
valdecoxib results in increased expression of SLC35E3 mRNA
CTD
PMID:24136188
NCBI chr 7:53,337,091...53,350,152
Ensembl chr 7:53,337,095...53,350,165
G
Slc37a4
solute carrier family 37 member 4
decreases expression
EXP
valdecoxib results in decreased expression of SLC37A4 mRNA
CTD
PMID:24136188
NCBI chr 8:53,619,952...53,626,110
Ensembl chr 8:44,723,339...44,729,301
G
Slc39a10
solute carrier family 39 member 10
increases expression
EXP
valdecoxib results in increased expression of SLC39A10 mRNA
CTD
PMID:24136188
NCBI chr 9:62,331,281...62,454,754
Ensembl chr 9:54,876,141...54,960,325
G
Slc3a2
solute carrier family 3 member 2
increases expression
EXP
valdecoxib results in increased expression of SLC3A2 mRNA
CTD
PMID:24136188
NCBI chr 1:215,033,601...215,048,064
Ensembl chr 1:205,604,468...205,618,931
G
Slc43a1
solute carrier family 43 member 1
increases expression
EXP
valdecoxib results in increased expression of SLC43A1 mRNA
CTD
PMID:24136188
NCBI chr 3:90,327,250...90,353,438
Ensembl chr 3:69,920,649...69,946,768
G
Slc45a3
solute carrier family 45, member 3
decreases expression
EXP
valdecoxib results in decreased expression of SLC45A3 mRNA
CTD
PMID:24136188
NCBI chr13:45,959,467...45,979,763
Ensembl chr13:43,407,293...43,427,588
G
Slc46a1
solute carrier family 46 member 1
decreases expression
EXP
valdecoxib results in decreased expression of SLC46A1 mRNA
CTD
PMID:24136188
NCBI chr10:63,859,551...63,865,987
Ensembl chr10:63,361,486...63,368,848
G
Slc4a1
solute carrier family 4 member 1 (Diego blood group)
decreases expression
EXP
valdecoxib results in decreased expression of SLC4A1 mRNA
CTD
PMID:24136188
NCBI chr10:87,807,010...87,823,274
Ensembl chr10:87,306,872...87,323,117
G
Slc6a12
solute carrier family 6 member 12
decreases expression
EXP
valdecoxib results in decreased expression of SLC6A12 mRNA
CTD
PMID:24136188
NCBI chr 4:156,257,518...156,275,870
Ensembl chr 4:154,585,500...154,603,750
G
Slco1a4
solute carrier organic anion transporter family, member 1a4
increases expression
EXP
valdecoxib results in increased expression of SLCO1A2 mRNA
CTD
PMID:24136188
NCBI chr 4:176,441,104...176,495,846
Ensembl chr 4:174,710,004...175,254,573
G
Slco2a1
solute carrier organic anion transporter family, member 2a1
decreases expression
EXP
valdecoxib results in decreased expression of SLCO2A1 mRNA
CTD
PMID:24136188
NCBI chr 8:103,588,916...103,672,546
Ensembl chr 8:103,588,916...103,672,546
G
Slco2b1
solute carrier organic anion transporter family, member 2b1
decreases expression
EXP
valdecoxib results in decreased expression of SLCO2B1 mRNA
CTD
PMID:24136188
NCBI chr 1:163,371,410...163,419,412
Ensembl chr 1:153,959,293...154,007,353
G
Smim1
small integral membrane protein 1 (Vel blood group)
decreases expression
EXP
valdecoxib results in decreased expression of SMIM1 mRNA
CTD
PMID:24136188
NCBI chr 5:169,861,751...169,867,070
G
Smoc1
SPARC related modular calcium binding 1
decreases expression
EXP
valdecoxib results in decreased expression of SMOC1 mRNA
CTD
PMID:24136188
NCBI chr 6:106,432,592...106,593,956
Ensembl chr 6:100,701,346...100,862,699
G
Smyd4
SET and MYND domain containing 4
decreases expression
EXP
valdecoxib results in decreased expression of SMYD4 mRNA
CTD
PMID:24136188
NCBI chr10:60,200,067...60,246,387
Ensembl chr10:60,200,114...60,246,387
G
Snrnp48
small nuclear ribonucleoprotein U11/U12 subunit 48
increases expression
EXP
valdecoxib results in increased expression of SNRNP48 mRNA
CTD
PMID:24136188
NCBI chr17:26,596,266...26,616,058
Ensembl chr17:26,596,275...26,616,040
G
Snrpa
small nuclear ribonucleoprotein polypeptide A
increases expression
EXP
valdecoxib results in increased expression of SNRPA mRNA
CTD
PMID:24136188
NCBI chr 1:91,609,419...91,618,119
Ensembl chr 1:82,481,770...82,490,538
G
Snrpd3
small nuclear ribonucleoprotein D3 polypeptide
increases expression
EXP
valdecoxib results in increased expression of SNRPD3 mRNA
CTD
PMID:24136188
NCBI chr20:13,129,555...13,145,100
Ensembl chr20:13,130,119...13,145,978
G
Snrpg
small nuclear ribonucleoprotein polypeptide G
increases expression
EXP
valdecoxib results in increased expression of SNRPG mRNA
CTD
PMID:24136188
NCBI chr 4:120,369,676...120,377,263
Ensembl chr 4:118,812,252...118,819,826 Ensembl chr X:118,812,252...118,819,826
G
Snx11
sorting nexin 11
decreases expression
EXP
valdecoxib results in decreased expression of SNX11 mRNA
CTD
PMID:24136188
NCBI chr10:82,238,475...82,249,264
Ensembl chr10:81,742,024...81,752,712
G
Sod2
superoxide dismutase 2
increases expression
EXP
valdecoxib results in increased expression of SOD2 mRNA
CTD
PMID:24136188
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Spink1
serine peptidase inhibitor, Kazal type 1
decreases expression
EXP
valdecoxib results in decreased expression of SPINK1 mRNA
CTD
PMID:24136188
NCBI chr18:36,121,626...36,133,596
Ensembl chr18:35,824,550...35,882,642
G
Spryd7
SPRY domain containing 7
increases expression
EXP
valdecoxib results in increased expression of SPRYD7 mRNA
CTD
PMID:24136188
NCBI chr15:39,883,237...39,903,770
Ensembl chr15:35,707,060...35,727,509
G
Sptan1
spectrin, alpha, non-erythrocytic 1
increases expression
EXP
valdecoxib results in increased expression of SPTAN1 mRNA
CTD
PMID:24136188
NCBI chr 3:13,241,164...13,306,047
Ensembl chr 3:13,241,217...13,306,046
G
Sptbn2
spectrin, beta, non-erythrocytic 2
increases expression
EXP
valdecoxib results in increased expression of SPTBN2 mRNA
CTD
PMID:24136188
NCBI chr 1:211,432,373...211,473,016
Ensembl chr 1:202,002,970...202,044,283
G
Sqle
squalene epoxidase
increases expression
EXP
valdecoxib results in increased expression of SQLE mRNA
CTD
PMID:24136188
NCBI chr 7:92,758,175...92,773,049
Ensembl chr 7:90,868,011...90,883,618
G
Srd5a3
steroid 5 alpha-reductase 3
increases expression
EXP
valdecoxib results in increased expression of SRD5A3 mRNA
CTD
PMID:24136188
NCBI chr14:32,400,603...32,414,987
Ensembl chr14:32,046,408...32,060,747
G
Srebf1
sterol regulatory element binding transcription factor 1
decreases expression
EXP
valdecoxib results in decreased expression of SREBF1 mRNA
CTD
PMID:24136188
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,007,637...45,029,650
G
Srebf2
sterol regulatory element binding transcription factor 2
increases expression
EXP
valdecoxib results in increased expression of SREBF2 mRNA
CTD
PMID:24136188
NCBI chr 7:115,542,774...115,600,945
Ensembl chr 7:113,663,202...113,720,848
G
Sri
sorcin
increases expression
EXP
valdecoxib results in increased expression of SRI mRNA
CTD
PMID:24136188
NCBI chr 4:26,928,338...26,952,980
Ensembl chr 4:25,966,750...25,998,077
G
Srm
spermidine synthase
increases expression
EXP
valdecoxib results in increased expression of SRM mRNA
CTD
PMID:24136188
NCBI chr 5:164,309,002...164,312,203
Ensembl chr 5:159,025,873...159,029,405
G
St6gal1
ST6 beta-galactoside alpha-2,6-sialyltransferase 1
decreases expression
EXP
valdecoxib results in decreased expression of ST6GAL1 mRNA
CTD
PMID:24136188
NCBI chr11:77,526,837...77,653,474
Ensembl chr11:77,526,837...77,653,310
G
St8sia3
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3
decreases expression
EXP
valdecoxib results in decreased expression of ST8SIA3 mRNA
CTD
PMID:24136188
NCBI chr18:57,754,349...57,760,839
Ensembl chr18:57,754,347...57,760,839
G
Stac3
SH3 and cysteine rich domain 3
decreases expression
EXP
valdecoxib results in decreased expression of STAC3 mRNA
CTD
PMID:24136188
NCBI chr 7:65,227,151...65,235,884
Ensembl chr 7:63,343,186...63,350,589
G
Stag1
STAG1 cohesin complex component
decreases expression
EXP
valdecoxib results in decreased expression of STAG1 mRNA
CTD
PMID:24136188
NCBI chr 8:110,057,981...110,443,666
Ensembl chr 8:101,179,039...101,564,677
G
Stard3nl
STARD3 N-terminal like
increases expression
EXP
valdecoxib results in increased expression of STARD3NL mRNA
CTD
PMID:24136188
NCBI chr17:45,583,278...45,617,226
Ensembl chr17:45,583,266...45,617,226
G
Stard5
StAR-related lipid transfer domain containing 5
decreases expression
EXP
valdecoxib results in decreased expression of STARD5 mRNA
CTD
PMID:24136188
NCBI chr 1:147,015,304...147,025,170
Ensembl chr 1:137,606,177...137,616,469
G
Stat3
signal transducer and activator of transcription 3
increases expression
EXP
valdecoxib results in increased expression of STAT3 mRNA
CTD
PMID:24136188
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
G
Stbd1
starch binding domain 1
increases expression
EXP
valdecoxib results in increased expression of STBD1 mRNA
CTD
PMID:24136188
NCBI chr14:15,754,769...15,758,174
Ensembl chr14:15,469,582...15,477,443
G
Steap3
STEAP3 metalloreductase
decreases expression
EXP
valdecoxib results in decreased expression of STEAP3 mRNA
CTD
PMID:24136188
NCBI chr13:33,904,710...33,950,100
Ensembl chr13:31,351,954...31,396,519
G
Stip1
stress-induced phosphoprotein 1
increases expression
EXP
valdecoxib results in increased expression of STIP1 mRNA
CTD
PMID:24136188
NCBI chr 1:213,638,641...213,657,654
Ensembl chr 1:204,178,932...204,228,476
G
Sult1a1
sulfotransferase family 1A member 1
decreases expression
EXP
valdecoxib results in decreased expression of SULT1A1 mRNA
CTD
PMID:24136188
NCBI chr 1:190,702,592...190,706,112
Ensembl chr 1:181,272,023...181,275,562
G
Suox
sulfite oxidase
decreases expression
EXP
valdecoxib results in decreased expression of SUOX mRNA
CTD
PMID:24136188
NCBI chr 7:1,687,666...1,691,759
Ensembl chr 7:1,103,151...1,107,038
G
Sytl2
synaptotagmin-like 2
decreases expression
EXP
valdecoxib results in decreased expression of SYTL2 mRNA
CTD
PMID:24136188
NCBI chr 1:153,685,403...153,791,758
Ensembl chr 1:144,273,360...144,379,222
G
Tat
tyrosine aminotransferase
decreases expression
EXP
valdecoxib results in decreased expression of TAT mRNA
CTD
PMID:24136188
NCBI chr19:54,856,604...54,867,168
Ensembl chr19:37,947,112...37,958,031
G
Tbc1d15
TBC1 domain family, member 15
increases expression
EXP
valdecoxib results in increased expression of TBC1D15 mRNA
CTD
PMID:24136188
NCBI chr 7:52,690,770...52,746,309
Ensembl chr 7:50,804,012...50,860,175
G
Tbl3
transducin (beta)-like 3
increases expression
EXP
valdecoxib results in increased expression of TBL3 mRNA
CTD
PMID:24136188
NCBI chr10:14,230,660...14,235,873
Ensembl chr10:13,726,129...13,731,372
G
Tcp1
t-complex 1
increases expression
EXP
valdecoxib results in increased expression of TCP1 mRNA
CTD
PMID:24136188
NCBI chr 1:50,376,848...50,384,527
Ensembl chr 1:47,828,652...47,836,839
G
Tex2
testis expressed 2
increases expression
EXP
valdecoxib results in increased expression of TEX2 mRNA
CTD
PMID:24136188
NCBI chr10:91,436,629...91,546,240
Ensembl chr10:91,436,694...91,546,270
G
Tfam
transcription factor A, mitochondrial
increases expression
EXP
valdecoxib results in increased expression of TFAM mRNA
CTD
PMID:24136188
NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,356,197...17,368,292
G
Thnsl2
threonine synthase-like 2
decreases expression
EXP
valdecoxib results in decreased expression of THNSL2 mRNA
CTD
PMID:24136188
NCBI chr 4:104,671,305...104,691,084
Ensembl chr 4:103,112,963...103,132,017
G
Thrsp
thyroid hormone responsive
decreases expression
EXP
valdecoxib results in decreased expression of THRSP mRNA
CTD
PMID:24136188
NCBI chr 1:161,134,640...161,138,964
Ensembl chr 1:151,723,086...151,728,075
G
Timm10b
translocase of inner mitochondrial membrane 10B
increases expression
EXP
valdecoxib results in increased expression of TIMM10B mRNA
CTD
PMID:24136188
NCBI chr 1:169,392,355...169,395,201
Ensembl chr 1:159,980,484...159,981,642 Ensembl chr20:159,980,484...159,981,642
G
Timm29
translocase of inner mitochondrial membrane 29
increases expression
EXP
valdecoxib results in increased expression of TIMM29 mRNA
CTD
PMID:24136188
NCBI chr 8:28,421,370...28,424,339
G
Tkfc
triokinase and FMN cyclase
decreases expression
EXP
valdecoxib results in decreased expression of TKFC mRNA
CTD
PMID:24136188
NCBI chr 1:216,664,446...216,677,815
Ensembl chr 1:207,236,557...207,252,737
G
Tkt
transketolase
increases expression
EXP
valdecoxib results in increased expression of TKT mRNA
CTD
PMID:24136188
NCBI chr16:5,729,381...5,755,170
Ensembl chr16:5,723,762...5,748,698
G
Tlcd4
TLC domain containing 4
increases expression
EXP
valdecoxib results in increased expression of TLCD4 mRNA
CTD
PMID:24136188
NCBI chr 2:209,284,873...209,360,156
Ensembl chr 2:209,289,732...209,341,353
G
Tle3
TLE family member 3, transcriptional corepressor
decreases expression
EXP
valdecoxib results in decreased expression of TLE3 mRNA
CTD
PMID:24136188
NCBI chr 8:70,753,182...70,799,080
Ensembl chr 8:61,858,200...61,903,493
G
Tm2d3
TM2 domain containing 3
increases expression
EXP
valdecoxib results in increased expression of TM2D3 mRNA
CTD
PMID:24136188
NCBI chr 1:119,267,194...119,277,094
Ensembl chr 1:119,264,576...119,277,099
G
Tmcc1
transmembrane and coiled-coil domain family 1
decreases expression
EXP
valdecoxib results in decreased expression of TMCC1 mRNA
CTD
PMID:24136188
NCBI chr 4:150,738,966...150,912,256
Ensembl chr 4:149,069,260...149,239,620
G
Tmem132a
transmembrane protein 132A
increases expression
EXP
valdecoxib results in increased expression of TMEM132A mRNA
CTD
PMID:24136188
NCBI chr 1:207,507,074...207,518,756
Ensembl chr 1:207,507,077...207,518,758
G
Tmem135
transmembrane protein 135
increases expression
EXP
valdecoxib results in increased expression of TMEM135 mRNA
CTD
PMID:24136188
NCBI chr 1:152,418,929...152,692,405
Ensembl chr 1:143,006,344...143,221,171
G
Tmem218
transmembrane protein 218
decreases expression
EXP
valdecoxib results in decreased expression of TMEM218 mRNA
CTD
PMID:24136188
NCBI chr 8:36,924,553...36,940,564
Ensembl chr 8:36,924,585...36,939,927
G
Tmem259
transmembrane protein 259
increases expression
EXP
valdecoxib results in increased expression of TMEM259 mRNA
CTD
PMID:24136188
NCBI chr 7:10,374,804...10,381,566
Ensembl chr 7:9,722,485...9,730,932
G
Tmem30b
transmembrane protein 30B
increases expression
EXP
valdecoxib results in increased expression of TMEM30B mRNA
CTD
PMID:24136188
NCBI chr 6:97,987,471...97,990,546
Ensembl chr 6:92,249,790...92,254,842
G
Tnf
tumor necrosis factor
increases expression
EXP
valdecoxib results in increased expression of TNF
CTD
PMID:24136188
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
increases expression
EXP
valdecoxib results in increased expression of TNFRSF1A mRNA
CTD
PMID:24136188
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:158,150,820...158,163,591
G
Tnpo1
transportin 1
increases expression
EXP
valdecoxib results in increased expression of TNPO1 mRNA
CTD
PMID:24136188
NCBI chr 2:31,941,731...32,034,366
Ensembl chr 2:30,211,510...30,300,375
G
Tom1
target of myb1 membrane trafficking protein
decreases expression
EXP
valdecoxib results in decreased expression of TOM1 mRNA
CTD
PMID:24136188
NCBI chr19:13,411,227...13,446,129
Ensembl chr19:13,405,501...13,440,384
G
Tpm1
tropomyosin 1
increases expression
EXP
valdecoxib results in increased expression of TPM1 mRNA
CTD
PMID:24136188
NCBI chr 8:76,516,654...76,543,661
Ensembl chr 8:67,635,479...67,662,802
G
Trib3
tribbles pseudokinase 3
increases expression
EXP
valdecoxib results in increased expression of TRIB3 mRNA
CTD
PMID:24136188
NCBI chr 3:161,269,939...161,275,533
Ensembl chr 3:140,809,043...140,814,497
G
Trim37
tripartite motif-containing 37
increases expression
EXP
valdecoxib results in increased expression of TRIM37 mRNA
CTD
PMID:24136188
NCBI chr10:72,440,672...72,572,831
Ensembl chr10:71,943,375...72,075,558
G
Trim5
tripartite motif-containing 5
decreases expression
EXP
valdecoxib results in decreased expression of TRIM5 mRNA
CTD
PMID:24136188
NCBI chr 1:168,132,277...168,149,263
Ensembl chr 1:158,720,410...158,814,012
G
Tsc22d1
TSC22 domain family, member 1
decreases expression
EXP
valdecoxib results in decreased expression of TSC22D1 mRNA
CTD
PMID:24136188
NCBI chr15:58,159,612...58,260,244
Ensembl chr15:51,749,510...51,850,958
G
Tsc22d3
TSC22 domain family, member 3
decreases expression
EXP
valdecoxib results in decreased expression of TSC22D3 mRNA
CTD
PMID:24136188
NCBI chr X:109,006,410...109,066,389
Ensembl chr X:104,217,925...104,276,861
G
Tspyl4
TSPY-like 4
decreases expression
EXP
valdecoxib results in decreased expression of TSPYL4 mRNA
CTD
PMID:24136188
NCBI chr20:38,098,756...38,100,752
Ensembl chr20:38,098,677...38,103,053
G
Ttc27
tetratricopeptide repeat domain 27
increases expression
EXP
valdecoxib results in increased expression of TTC27 mRNA
CTD
PMID:24136188
NCBI chr 6:26,310,696...26,454,045
Ensembl chr 6:20,558,756...20,702,115
G
Tuba1c
tubulin, alpha 1C
increases expression
EXP
valdecoxib results in increased expression of TUBA1C mRNA
CTD
PMID:24136188
NCBI chr 7:131,636,974...132,078,589
Ensembl chr 7:130,192,016...130,199,647 Ensembl chr X:130,192,016...130,199,647
G
Tuba4a
tubulin, alpha 4A
increases expression
EXP
valdecoxib results in increased expression of TUBA4A mRNA
CTD
PMID:24136188
NCBI chr 9:84,158,871...84,174,041
Ensembl chr 9:76,709,614...76,713,918
G
Tubb4b
tubulin, beta 4B class IVb
increases expression
EXP
valdecoxib results in increased expression of TUBB4B mRNA
CTD
PMID:24136188
NCBI chr 3:28,435,999...28,438,455
Ensembl chr 3:8,037,799...8,040,296
G
Txn1
thioredoxin 1
increases expression
EXP
valdecoxib results in increased expression of TXN1 mRNA
CTD
PMID:24136188
NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:72,711,933...72,724,629
G
Txnl1
thioredoxin-like 1
increases expression
EXP
valdecoxib results in increased expression of TXNL1 mRNA
CTD
PMID:24136188
NCBI chr18:57,125,362...57,155,167
Ensembl chr18:57,125,369...57,165,266
G
Txnrd1
thioredoxin reductase 1
increases expression
EXP
valdecoxib results in increased expression of TXNRD1 mRNA
CTD
PMID:24136188
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:20,830,045...20,907,863
G
Uap1
UDP-N-acetylglucosamine pyrophosphorylase 1
decreases expression
EXP
valdecoxib results in decreased expression of UAP1 mRNA
CTD
PMID:24136188
NCBI chr13:84,875,719...84,910,706
Ensembl chr13:82,342,946...82,377,469 Ensembl chr 6:82,342,946...82,377,469
G
Ube2c
ubiquitin-conjugating enzyme E2C
decreases expression
EXP
valdecoxib results in decreased expression of UBE2C mRNA
CTD
PMID:24136188
NCBI chr 3:173,925,975...173,928,375
Ensembl chr 3:153,506,636...153,513,339
G
Ube4b
ubiquitination factor E4B
increases expression
EXP
valdecoxib results in increased expression of UBE4B mRNA
CTD
PMID:24136188
NCBI chr 5:159,766,829...159,870,509
Ensembl chr 5:159,766,829...159,870,509
G
Ubqln1
ubiquilin 1
increases expression
EXP
valdecoxib results in increased expression of UBQLN1 mRNA
CTD
PMID:24136188
NCBI chr17:6,438,456...6,482,498
Ensembl chr17:6,439,002...6,477,090
G
Ubqln2
ubiquilin 2
increases expression
EXP
valdecoxib results in increased expression of UBQLN2 mRNA
CTD
PMID:24136188
NCBI chr X:21,228,809...21,232,228
Ensembl chr X:17,853,114...17,856,505
G
Ubr3
ubiquitin protein ligase E3 component n-recognin 3
increases expression
EXP
valdecoxib results in increased expression of UBR3 mRNA
CTD
PMID:24136188
NCBI chr 3:54,649,803...54,806,779
Ensembl chr 3:54,649,992...54,806,247
G
Ubxn2a
UBX domain protein 2A
increases expression
EXP
valdecoxib results in increased expression of UBXN2A mRNA
CTD
PMID:24136188
NCBI chr 6:33,603,804...33,645,958
Ensembl chr 6:27,884,680...27,912,649 Ensembl chr20:27,884,680...27,912,649
G
Ubxn4
UBX domain protein 4
increases expression
EXP
valdecoxib results in increased expression of UBXN4 mRNA
CTD
PMID:24136188
NCBI chr13:39,740,064...39,772,493
Ensembl chr13:39,740,107...39,772,491
G
Ufd1
ubiquitin recognition factor in ER associated degradation 1
increases expression
EXP
valdecoxib results in increased expression of UFD1 mRNA
CTD
PMID:24136188
NCBI chr11:95,665,971...95,689,423
Ensembl chr11:82,161,619...82,185,087
G
Ugdh
UDP-glucose 6-dehydrogenase
increases expression
EXP
valdecoxib results in increased expression of UGDH mRNA
CTD
PMID:24136188
NCBI chr14:43,202,480...43,226,002
Ensembl chr14:42,848,854...42,872,354
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
increases expression
EXP
valdecoxib results in increased expression of UGT1A6 mRNA
CTD
PMID:24136188
NCBI chr 9:96,195,018...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Ugt2a1
UDP glucuronosyltransferase family 2 member A1
increases expression
EXP
valdecoxib results in increased expression of UGT2A1 mRNA
CTD
PMID:24136188
NCBI chr14:20,797,262...20,825,111
Ensembl chr14:20,517,951...20,545,531
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
increases expression
EXP
valdecoxib results in increased expression of UGT2B17 mRNA
CTD
PMID:24136188
NCBI chr14:21,378,882...21,390,631
Ensembl chr14:21,024,006...21,035,986
G
Unc5cl
unc-5 family C-terminal like
increases expression
EXP
valdecoxib results in increased expression of UNC5CL mRNA
CTD
PMID:24136188
NCBI chr 9:12,528,109...12,543,382
Ensembl chr 9:12,528,246...12,542,233
G
Unkl
unk like zinc finger
increases expression
EXP
valdecoxib results in increased expression of UNKL mRNA
CTD
PMID:24136188
NCBI chr10:14,710,627...14,756,725
Ensembl chr10:14,206,189...14,252,225
G
Uri1
URI1, prefoldin-like chaperone
increases expression
EXP
valdecoxib results in increased expression of URI1 mRNA
CTD
PMID:24136188
NCBI chr 1:99,783,157...99,845,787
Ensembl chr 1:90,646,393...90,709,026
G
Usp14
ubiquitin specific peptidase 14
increases expression
EXP
valdecoxib results in increased expression of USP14 mRNA
CTD
PMID:24136188
NCBI chr18:1,292,745...1,330,867
Ensembl chr18:1,019,400...1,057,519
G
Usp2
ubiquitin specific peptidase 2
decreases expression
EXP
valdecoxib results in decreased expression of USP2 mRNA
CTD
PMID:24136188
NCBI chr 8:44,411,457...44,439,668
Ensembl chr 8:44,411,607...44,438,331
G
Usp33
ubiquitin specific peptidase 33
increases expression
EXP
valdecoxib results in increased expression of USP33 mRNA
CTD
PMID:24136188
NCBI chr 2:243,938,958...243,988,424
Ensembl chr 2:241,292,985...241,328,479
G
Usp5
ubiquitin specific peptidase 5
increases expression
EXP
valdecoxib results in increased expression of USP5 mRNA
CTD
PMID:24136188
NCBI chr 4:159,305,927...159,321,345
Ensembl chr 4:157,619,643...157,634,711
G
Vav2
vav guanine nucleotide exchange factor 2
increases expression
EXP
valdecoxib results in increased expression of VAV2 mRNA
CTD
PMID:24136188
NCBI chr 3:30,982,754...31,152,116
Ensembl chr 3:10,584,688...10,754,052
G
Vcp
valosin-containing protein
increases expression
EXP
valdecoxib results in increased expression of VCP mRNA
CTD
PMID:24136188
NCBI chr 5:62,005,984...62,025,387
Ensembl chr 5:57,210,168...57,229,571
G
Vegfa
vascular endothelial growth factor A
increases secretion
ISO
valdecoxib results in increased secretion of VEGFA protein
CTD
PMID:24431307
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Vegfb
vascular endothelial growth factor B
increases expression
EXP
valdecoxib results in increased expression of VEGFB mRNA
CTD
PMID:24136188
NCBI chr 1:213,601,570...213,607,254
Ensembl chr 1:204,172,225...204,177,944
G
Veph1
ventricular zone expressed PH domain-containing 1
decreases expression
EXP
valdecoxib results in decreased expression of VEPH1 mRNA
CTD
PMID:24136188
NCBI chr 2:150,291,379...150,537,491
Ensembl chr 2:150,296,573...150,537,266
G
Vnn1
vanin 1
increases expression
EXP
valdecoxib results in increased expression of VNN1 mRNA
CTD
PMID:24136188
NCBI chr 1:23,356,324...23,366,629
Ensembl chr 1:21,537,094...21,547,395
G
Vps26a
VPS26 retromer complex component A
increases expression
EXP
valdecoxib results in increased expression of VPS26A mRNA
CTD
PMID:24136188
NCBI chr20:30,947,018...30,976,964
Ensembl chr20:30,404,325...30,434,131
G
Vwa8
von Willebrand factor A domain containing 8
increases expression
EXP
valdecoxib results in increased expression of VWA8 mRNA
CTD
PMID:24136188
NCBI chr15:54,252,703...54,576,871
Ensembl chr15:54,252,584...54,576,870
G
Wdr33
WD repeat domain 33
decreases expression
EXP
valdecoxib results in decreased expression of WDR33 mRNA
CTD
PMID:24136188
NCBI chr18:23,432,233...23,535,460
Ensembl chr18:23,432,191...23,468,597
G
Wdr6
WD repeat domain 6
decreases expression
EXP
valdecoxib results in decreased expression of WDR6 mRNA
CTD
PMID:24136188
NCBI chr 8:118,146,608...118,153,024
Ensembl chr 8:109,268,079...109,274,499
G
Wwc1
WW and C2 domain containing 1
increases expression
EXP
valdecoxib results in increased expression of WWC1 mRNA
CTD
PMID:24136188
NCBI chr10:20,804,173...20,958,437
Ensembl chr10:20,300,833...20,454,497
G
Xiap
X-linked inhibitor of apoptosis
decreases expression
EXP
valdecoxib results in decreased expression of XIAP mRNA
CTD
PMID:24136188
NCBI chr X:125,756,107...125,803,979
Ensembl chr X:120,897,907...120,934,700
G
Xpc
XPC complex subunit, DNA damage recognition and repair factor
decreases expression
EXP
valdecoxib results in decreased expression of XPC mRNA
CTD
PMID:24136188
NCBI chr 4:125,550,833...125,578,084
Ensembl chr 4:123,993,666...124,021,010
G
Xpnpep2
X-prolyl aminopeptidase 2
decreases expression
EXP
valdecoxib results in decreased expression of XPNPEP2 mRNA
CTD
PMID:24136188
NCBI chr X:132,165,696...132,194,937
Ensembl chr X:127,287,979...127,317,223
G
Xpot
exportin for tRNA
increases expression
EXP
valdecoxib results in increased expression of XPOT mRNA
CTD
PMID:24136188
NCBI chr 7:58,997,025...59,037,506
Ensembl chr 7:57,111,536...57,152,099
G
Yars2
tyrosyl-tRNA synthetase 2
increases expression
EXP
valdecoxib results in increased expression of YARS2 mRNA
CTD
PMID:24136188
NCBI chr11:98,136,530...98,142,320
Ensembl chr11:84,624,369...84,638,125
G
Zan
zonadhesin
increases expression
EXP
valdecoxib results in increased expression of ZAN mRNA
CTD
PMID:24136188
NCBI chr12:24,851,798...24,963,837
Ensembl chr12:19,215,102...19,271,240
G
Zdhhc2
zinc finger DHHC-type palmitoyltransferase 2
increases expression
EXP
valdecoxib results in increased expression of ZDHHC2 mRNA
CTD
PMID:24136188
NCBI chr16:58,511,931...58,581,530
Ensembl chr16:51,808,468...51,878,060
G
Zfand2a
zinc finger AN1-type containing 2A
increases expression
EXP
valdecoxib results in increased expression of ZFAND2A mRNA
CTD
PMID:24136188
NCBI chr12:15,161,601...15,172,679
Ensembl chr12:15,161,639...15,172,677
G
Zfand5
zinc finger AN1-type containing 5
increases expression
EXP
valdecoxib results in increased expression of ZFAND5 mRNA
CTD
PMID:24136188
NCBI chr 1:218,765,735...218,780,391
Ensembl chr 1:218,766,614...218,775,843
G
Zfp189
zinc finger protein 189
decreases expression
EXP
valdecoxib results in decreased expression of ZFP189 mRNA
CTD
PMID:24136188
NCBI chr 5:63,872,596...63,884,348
Ensembl chr 5:63,872,738...63,884,121
G
Zfp266
zinc finger protein 266
decreases expression
EXP
valdecoxib results in decreased expression of ZFP266 mRNA
CTD
PMID:24136188
NCBI chr 8:27,307,015...27,338,624
Ensembl chr 8:19,030,768...19,060,937
G
Zfp292
zinc finger protein 292
increases expression
EXP
valdecoxib results in increased expression of ZFP292 mRNA
CTD
PMID:24136188
NCBI chr 5:54,184,174...54,264,454
Ensembl chr 5:49,387,893...49,468,265
G
Zfp354a
zinc finger protein 354A
decreases expression
EXP
valdecoxib results in decreased expression of ZFP354A mRNA
CTD
PMID:24136188
NCBI chr10:35,897,217...35,909,063
Ensembl chr10:35,396,231...35,408,068
G
Zfp36l2
zinc finger protein 36, C3H type-like 2
increases expression
EXP
valdecoxib results in increased expression of ZFP36L2 mRNA
CTD
PMID:24136188
NCBI chr 6:16,242,622...16,246,662
Ensembl chr 6:10,490,032...10,494,064
G
Zfp593
zinc finger protein 593
increases expression
EXP
valdecoxib results in increased expression of ZFP593 mRNA
CTD
PMID:24136188
NCBI chr 5:146,462,670...146,464,998
Ensembl chr 5:146,462,670...146,465,198
G
Zrsr2-ps1
zinc finger (CCCH type), RNA binding motif and serine/arginine rich 2, pseudogene 1
increases expression
EXP
valdecoxib results in increased expression of ZRSR2-PS1 mRNA
CTD
PMID:24136188
NCBI chr14:96,972,651...96,978,364
Ensembl chr14:96,972,580...96,978,891
G
Zwint
ZW10 interacting kinetochore protein
increases expression
EXP
valdecoxib results in increased expression of ZWINT mRNA
CTD
PMID:24136188
NCBI chr20:15,502,559...15,953,701
Ensembl chr20:15,938,157...15,953,957
G
Cdh1
cadherin 1
increases expression
ISO
parecoxib results in increased expression of CDH1 protein
CTD
PMID:35917206
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:34,492,371...34,561,775
G
Cnr1
cannabinoid receptor 1
increases response to substance
ISO
CNR1 protein results in increased susceptibility to parecoxib
CTD
PMID:23371449
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:48,408,574...48,435,099
G
Ctnnb1
catenin beta 1
decreases expression
ISO
parecoxib results in decreased expression of CTNNB1 protein
CTD
PMID:35917206
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Gsk3b
glycogen synthase kinase 3 beta
decreases expression increases expression
ISO
parecoxib results in decreased expression of GSK3B protein modified form parecoxib results in increased expression of GSK3B protein
CTD
PMID:35917206
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
G
Macc1
MET transcriptional regulator MACC1
decreases expression
ISO
parecoxib results in decreased expression of MACC1 protein
CTD
PMID:35917206
NCBI chr 6:146,495,544...146,574,254
Ensembl chr 6:140,352,755...140,430,255
G
Mapk1
mitogen activated protein kinase 1
decreases phosphorylation
ISO
parecoxib results in decreased phosphorylation of MAPK1 protein
CTD
PMID:35917206
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
decreases phosphorylation
ISO
parecoxib results in decreased phosphorylation of MAPK3 protein
CTD
PMID:35917206
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
increases phosphorylation
ISO
parecoxib results in increased phosphorylation of MAPK8 protein
CTD
PMID:35917206
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Mapk9
mitogen-activated protein kinase 9
increases phosphorylation
ISO
parecoxib results in increased phosphorylation of MAPK9 protein
CTD
PMID:35917206
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,169,675...34,210,178
G
Met
MET proto-oncogene, receptor tyrosine kinase
decreases expression
ISO
parecoxib results in decreased expression of MET protein
CTD
PMID:35917206
NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:45,790,791...45,897,876
G
Vim
vimentin
decreases expression
ISO
parecoxib results in decreased expression of VIM protein
CTD
PMID:35917206
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:76,668,647...76,677,187
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all